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ABSTRACT 
 
Biotechnologies in post-genomic era, especially those that generate data in high-
throughput, bring opportunities and challenges that are never faced before. And one of 
them is how to decode big heterogeneous data for clues that are useful for biological 
questions. With the exponential growth of a variety of data, comes with more and more 
applications of systematic approaches that investigate biological questions in an integrative 
way. Systematic approaches inherently require integration of heterogeneous information, 
which is urgently calling for a lot more efforts.   
In this thesis, the effort is mainly devoted to the development of methods and tools 
that help to integrate big heterogeneous information.  In Chapter 2, we employed a 
heuristic strategy to summarize/integrate genes that are essential for the determination of 
mouse retinal cells in the format of network. These networks with experimental evidence 
could be rediscovered in the analysis of high-throughput data set and thus would be useful 
in the leverage of high-throughput data.  In Chapter 3, we described EnRICH, a tool that we 
developed to help qualitatively integrate heterogeneous intra-organism information. We 
also introduced how EnRICH could be applied to the construction of a composite network 
from different sources, and demonstrated how we used EnRICH to successfully prioritize 
retinal disease genes. Following the work of Chapter 3 (intra-organism information 
integration), in Chapter 4 we stepped to the development of method and tool that can help 
deal with inter-organism information integration. The method we proposed is able to 
match genes in a one-to-one fashion between any two genomes.  
In summary, this thesis contributes to integrative analysis of big heterogeneous data 
by its work on the integration of intra- and inter-organism information
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CHAPTER 1 
 
GENERAL INTRODUCTION 
 
1.1 The structure of this thesis 
 
 
 
Background (Chapter 1): I describe the big picture that this thesis relates to and 
provide essential background knowledge. 
General statement of problems (Chapter 1):  I summarize general problems that we 
can try to solve within the scope of this thesis. 
Rationale and specific objectives (Chapter 1):  Based on the general statement of 
problems, I provide a rationale for and identify the specific objectives addressed in this 
thesis. 
Literature Review (Chapter 1):  I review concepts and the body of literature that is 
essential to the specific objectives addressed in this thesis.  
Chapter 2:  Mouse Retinal Development: a Dark Horse Model for Systems Biology 
Research, Bioinformatics and Biology Insights 2011: 5 99-113. I justify the use of the mouse 
retina as a powerful model system to explore systematic and integrative approaches. I then 
summarize gene networks employed in the developing mouse retina. Last, I describe how 
these networks were re-discovered using high-throughput data. 
Chapter 3: EnRICH: Extraction and Ranking using Integration and Criteria 
Heuristics, BMC Systems Biology 2013, 7:4.  I describe the software we developed to filter, 
as well as integrate, both list and network data and present a case study in which this 
software was successfully used to identify retinal disease genes. 
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Chapter 4: Plugging into the tree of life: genome –wide homolog identification 
between model and non-model organisms.  I introduce the genome-wide approach we 
proposed to match homologous genes/proteins in a one-to-one fashion between 
organisms, and present results on its performance. 
Chapter 5: I summarize the contribution of my thesis work to the scientific 
community. 
 
1.2 Background 
 
 
In 1990, the National Institutes of Health (NIH) and the Department of Energy 
(DOE) initiated the Human Genome Project (HGP)[1].  The human genome was estimated 
to have about 3 billion base pairs and with the technologies at the time, it was broken into 
smaller pieces with a length ranging from 150,000 to 200, 000 base pairs [1]. These smaller 
pieces were ligated into vectors of BACs so they could be inserted into bacteria and copied 
by bacterial DNA replication to make BAC clones .  With BAC clones, human DNA was 
prepared in quantities large enough for sequencing.  Before sequencing, each BAC clone 
was mapped to chromosomes to determine the precise location of the DNA sequence and 
its relationship to DNA sequences in other BAC clones [1].  Then, shotgun sequencing was 
applied to the DNA sequence in each BAC clone.  With this approach known as ‘hierarchical 
shotgun’ [2], it was expected to take 15 years to finish the HGP.  The private company 
Celera Genomics led by Craig Venter, a previous NIH scientist, claimed it would complete 
human genome sequencing using much less time and cost than the publicly funded team [3, 
4]. The Celera Genomics approach known as ‘whole genome shotgun’ used similar 
sequencing technologies, but differed from ‘hierarchical shotgun’ in the strategies to break 
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up sequences and then put them back together [5]. ‘Hierarchical shotgun’ broke up the 
whole genome into large fragments of DNA of known positions and then sequenced each 
fragment of DNA by shotgun sequencing. This strategy requires the construction of a 
whole-genome map of these DNA fragments. ‘Whole genome shotgun’ shredded the whole 
genome into small pieces that are directly sequenced and then all the small pieces were put 
back together based on sequence overlaps. Celera Genomics spurred the HGP team to 
change its strategy and sped up the completion of HGP.  In June 2000, the head of public 
HGP, Francis Collins, and that of Celera Genomics, Craig Venter, jointly announced the 
completion of human genome project, paving the way for post-genomic era. 
 
1.2.1 Revolutionary biotechnologies that shaped post-genomic era 
In addition to human genome project, Craig Venter also was involved in developing 
a gene discovery and tagging strategy known as Expressed Sequence Tags or ESTs[6] and 
pioneered its use in gene discovery [7, 8]. The technological advantage of this approach 
was that only a distinguishable fraction of cDNA was sequenced. So an EST is a sub-
sequence of one cloned cDNA. Since cDNA is complimentary to mRNA, ESTs also represent 
portions of expressed genes and can be used to identify gene transcripts. Since 1991 when 
the term EST was coined[6], EST data experienced an exponential growth. Likely because  
ESTs have a broad application in gene discovery, genome annotation, gene structure 
identification, and SNP characterization [9]. ESTs even exerted an important effect in the 
design of cDNA microarrays [10], the most significant technology in gene expression 
profiling before Next Generation Sequencing or NGS technologies became popular. 
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Microarray technology [11] evolved from Southern blotting [12], a method routinely 
used to detect a specific DNA sequence in DNA samples. The specific DNA sequence is a so-
called ‘probe’, and sequences in DNA samples that can be hybridized with the ‘probe’ are 
target sequences.  The core biological principle that the microarray utilizes is the same as 
Southern blotting. That is, the hybridization between two complementary DNA strands.  
But in microarray, instead of a single probe, there could be a large number of probes. In this 
way many tests can be simultaneously carried out to detect probes in target sequences.  
However, microarray technology is not simply an extension of Southern blotting by 
adding fluorescent technology [13]. Microarray technology requires solutions to at least 
three challenges. The first challenge is to put a synthesized probe on a solid chip. The 
second challenge is to generate detectable signals that can be quantitatively read to 
indicate the hybridization between target sequences and probes. Last, the target-probe 
signal must be separated from noise as cross hybridization may produce confounding 
signals. For the first challenge, Stephen Fodor and colleagues developed the techniques to 
synthesize oligonucleotides on a solid matrix by combinatorial chemistry synthesis [14]. 
They also solved the array-reading problem by adoption of fluorescent labeling techniques 
and confocal laser scanning, alleviating issues with the second challenge. For the third 
challenge, David Lockhart designed a single mismatch in oligonucleotide to eliminate 
confounding signals [15].  In 1993, Stephen Fodor co-founded Affymetrix [16], a company 
that produces a large variety of oligonucleotide microarrays. Based on the technology 
developed for DNA microarrays, other types of microarrays such as the protein microarray 
[17] and chemical compound microarray [18, 19] also emerged.  Important technology 
such as chromatin immunoprecipitation (ChIP)ChIP-chip [20, 21] became possible with 
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microarray.  Chromatin immunoprecipitation (ChIP) is a technique developed to 
investigate interactions between proteins and in vivo DNA, but when combined with 
microarray technology, these investigations can be genome-wide. That is, for a DNA-
binding protein of interest, its binding sites across the whole genome could be detected at 
the same time.  
As microarray technology became widely adopted in profiling gene expressions, 
next generation sequencing (NGS) technologies [22], driven by a strong demand in low cost 
sequencing, were also exponentially advanced [22, 23]. After the HGP was completed, 
several model organisms such as fly, mouse, rat, chicken, dog, etc. were also sequenced [24]. 
But the sequencing technology that generated these genomes was still Sanger-based 
capillary sequencing, the same as that worked in HGP.  The Sanger-dominant sequencing 
landscape shifted to a NGS one, as multiple commercial sequencing instruments became 
available since 2005.  These instruments all share a common mechanism of data generation 
that is radically different from Sanger-based capillary sequencing, though each of them has 
its distinct specifics regarding the method of library amplification, sequencing, detection 
and post-incorporation etc [25]. In sample preparation, BAC clones and DNA isolations are 
replaced by ligations of platform-specific adaptors to ends of DNA fragments and 
amplifications on solid surface.  In instrument use, sequencing reactions are designed as a 
series of automatic repeating steps instead of semi-automated implementation of Sanger 
chemistry, making these instruments able to generate a much higher throughput of 
sequences per run at a lower cost. The nice qualities of NGS technologies have led them to 
not only replace Sanger sequencing, but also to occupy what used to belong to DNA 
microarray. Looking back, EST data contains sequences of gene transcripts and helped to 
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design the platform of DNA microarray. DNA microarray profiles expressions of gene 
transcripts. Now, with RNA-Seq [26], both the sequences and expressions of gene 
transcripts can be investigated.  The aforementioned ChIP-chip is also evolving into ChIP-
Seq [27]. 
Though many technologies contribute to the status quo in post-genomic era, 
technologies described in the paragraphs above composed the theme of the story, and 
continue to play important roles as this revolution grows.  
 
1.2.2 Technology-driven opportunities and challenges 
In 2001, Francis Collins and Craig Venter published their reports on the human 
genome [2, 5] . Since then, more model organisms have been sequenced.  The availability of 
multiple genomes of model organisms led to the emergence of new fields, such as 
comparative genomics [28], which employs comparative analyses between two or more 
genomes. Studies on evolutionary relationships, gene identification and regulatory element 
identification embody the boom of comparative genomics.  
In parallel to comparative genomics is functional genomics. The early studies using 
microarrays made scientists realize that changes in gene expression in isolation are 
difficult to interpret without sufficient knowledge of these genes [29, 30]. To make sense of 
gene expression, an approach widely adopted by researchers was to identify putatively 
relevant genes by comparing gene expression between two phenotypes.  Microarray 
analysis became a powerful way to identify candidate genes for a phenotype of interest, 
accelerating the process to connect genotypes and phenotypes [31]. With microarray-
related technology such as ChIP-chip, scientists can generate interactions between DNA-
binding proteins and DNA in vivo in a high-throughput manner, escalating studies on 
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functional elements in the genome.  Functional genomics emerged [32, 33] and developed 
as a field to study properties and functions of genes and gene products by integrative 
utilization of data generated by high-throughput technologies.  
 As NGS rapidly develops, it becomes more and more affordable to sequence new 
genomes and profile transcriptomes, deepening and widening the biological questions that 
scientists can investigate. With the enormous opportunities brought by high-throughput 
technologies, come a variety of challenges that scientists never faced before. The first 
challenge is high-throughput data analysis requires knowledge of statistics, computer 
science and biology.  So it is important to optimize data analysis methods and to develop 
user-friendly ftools for biologists to easily organize the data and conduct the analysis[34, 
35]. The second challenge lies in the heterogeneous sources of data [36, 37]. Diverse data 
sources represent different lines of evidence, and leveraging all data is absolutely the ideal 
situation. However, this requires methods and tools that biologists can use to do an 
integrative analysis on different types of data in order to address questions that are better 
answered by such analysis.  The third challenge is, as high-throughput data increases 
exponentially, the old systems of storing, retrieving and analyzing data are becoming 
inefficient in, and even incapable of, providing what scientists need [38-40]. To tackle the 
three challenges, an interdisciplinary effort should be devoted to generate methods and 
tools that can cope with and interpret big, heterogeneous biological data as well as develop 
information systems that effectively handle the data flow. 
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1.2.3 Big and heterogeneous data and their analyses 
Overall, large, heterogeneous data can be grouped into several big categories.  The 
first category is nucleic acid sequence data, which mainly consists of genomic DNA 
sequences and several subgroups of RNA sequences (e.g. small RNA and ribosome RNA).  
The second category is gene expression data at the RNA-level that measures expressions of 
gene transcripts. To date, this category contains mostly high-throughput expression data 
such as microarray and RNA-Seq, and these data are very helpful to effectively infer gene 
activities in a spatially defined and time-resolved way.   The third category is protein data 
that includes protein-level expression, protein sequences and even secondary and three-
dimensional structures of proteins. In addition to protein-level expression, protein 
structures are also important indicators/predictors of their biological functions, helping to 
translate static genetic information to dynamic carriers of cellular activities. The fourth 
category is interaction data such as protein-protein interactions, protein-DNA/RNA 
interactions and genetic interactions. Protein-protein interactions and protein-DNA/RNA 
interactions are physical interactions detected by techniques such as yeast two-hybrid [41] 
and ChIP-chip/ChIP-Seq [42], while genetic interactions, for example, detected by double 
mutant animals, reveal functional relations. The fifth category is metabolic data including 
metabolites that are intermediates and products of metabolism and biochemical processes 
between them.  Metabolic data [43, 44] captures the cellular physiology that RNA 
expression and protein data alone cannot, and thus complements the big picture from 
genes to gene expressions to cellular activities. The sixth category is annotation data that 
comes from various sources such as standard biological annotation terms such as GO [45] 
and KEGG [46], and scientific literature or a more summarized version of them such as 
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Gene Wiki [47, 48]. Taken together, genomics data draws a map of a biological system. 
Transcriptomics and proteomics data illuminate intricate parts of this system while 
interaction data shows its underlying dynamics. Metabolic data can be seen as biochemical 
results that are generated from as well as interact with the intricacies of a biological 
system. They are very important to understanding how genetic information prints the 
integrative physiology of a biological system. Annotation data is contained in standard 
repositories that document what biologists learn about each aspect of this biological 
system and can be very helpful when leveraging from the known to study the unknown. In 
paragraphs below, data that reveal the inner side of a biological system, that is, genomics, 
transcriptomics and proteomics data, will be discussed with regards to its data analysis.  
Sequence data now are mostly from genome sequencing/ transcriptome profiling 
short reads generated by an NGS platform. The major analysis is to assemble short reads 
into a genome or gene transcripts. The bioinformatics community has created a variety of 
algorithms and tools to deal with genome/transcriptome assembly [49-52].  Sequence 
assembly and alignment programs are the most important tools to analyze NGS data. Most 
sequence assembly programs adopt a/the De Bruijn graph as the data structure and 
assemble short reads to long contigs and then to scaffolds by resolving the De Bruijin 
graph[53, 54].  Assembly programs also cater to either genome or transcriptome assembly 
based on different requirements genomes and transcriptomes impose on them.  For 
example, a genome has many more repetitive regions and thus requires a huge and 
complicated De Bruijin graph to resolve, while transcripts are relatively small and utilize 
simple De Bruijin graphs. To identify structural changes such as a deletion, insertion, SNP, 
and CNV or to annotate genes/transcripts, aligners are must-run programs. Alignment 
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programs tuned to short reads employed FM-index on Burrow Wheeler transform, and 
those tuned to longer reads alignment use Hash-index and seed-to-extend strategy [55].  
Complementing assembly and alignment programs, some tools [56] such as PASA [57] and 
Blast2GO [58, 59] focus more on gene structure prediction and gene function annotation. 
Together these tools compose a source pool from which scientists can customize their own 
analysis pipelines targeting specific purposes. 
Gene transcript expression data has two sources: microarray and RNA-Seq. A typical 
microarray analysis pipeline includes pre-processing such as background correction, 
within array or across array normalization, and statistical analysis such as linear fitting and 
multiple testing to identify differentially expressed genes [30, 60, 61].  A variety of 
statistical methods and tools were developed for microarray data, as the microarray 
became a dominant method to profile gene expression [62].  R Bioconductor packages such 
as ‘affy’ and ‘limma’ became mainstream tools in scientific studies using microarrays [63], 
because these packages provide a full range of functions on microarray analysis and can be 
used in combination with other R packages to make the analysis more adaptable to specific 
needs.  RNA-Seq analysis shares the statistical philosophy of microarray analysis on the 
identification of differentially expressed genes even it requires statistical models different 
from what microarray analysis requires. However it can also have its own agenda in 
specific analyses and involves another spectrum of tools [64]. For example, from RNA-Seq 
data structural variations of transcripts can be detected while microarray does not provide 
such information. In RNA-Seq data, short reads must be aligned to assembled transcripts or 
reference genome and then summarized into expression counts and then normalized into 
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expression value.  In contrast, raw expression values in microarrays are usually the data 
handed to scientists and to get expression values only normalization is involved.   
In addition to gene transcript expression data, protein abundance data is also an 
important expression data subcategory. Due to alternative splicing, post-translational 
modification and protein degradation regulation, RNA-level expression is related to, but 
does not always correlate to protein-level expression [65, 66].  Proteomic studies that 
survey protein abundance provide a direct measure of protein-level expression.  There are 
two major ways of proteome analysis [67], the top-down and the bottom-up. The top-down 
means characterizing intact protein by mass spectrometry (MS) without proteolysis. Due to 
its technical challenges, the top-down is rarely used. The widely used bottom-up approach 
consists of protein fragmentation, fractionation and MS analysis [67]. In quantitative 
proteomics, peptide identification, peptide quantification and assembling from peptide to 
protein involve a wide range of methods, software and databases that are beyond the scope 
of work in this thesis. I referred to the review written by Matthiesen R [68] if the reader is 
interested in this topic.   
 
1.2.4 Systematic approaches 
The term “system” was rooted from general systems theory [69] and was defined as 
“an entity that maintains its existence through the mutual interaction of its parts.” Although 
systems biology has specific definitions from various fields, the consensus view of systems 
biology is a biological system with emergent properties that do not arise from an individual 
part or the linear assembly of them [70, 71]. In this thesis, systems biology is taken as a 
research methodology[72] to explore the systems behavior of a biological entity at 
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potential levels that cannot be studied by a reductionist methodology.  Specific approaches 
that adopt this methodology are referred as ‘systematic approaches’ here. 
Limitations of systems biology as a methodology include, but are not limited to, 
three factors. First, incomplete data makes model construction difficult and biased. Second, 
when heterogeneous data are incorporated, each dataset will have its own error and bias. 
Thus, it is challenging to make them comparable, complicating the error estimate and pre-
experiment evaluation of the model. Third, model validation by experiments often is not 
affordable. To overcome these limitations, a lot of more effort is still needed for data 
integration, model construction and model validation. 
Systems biology inherently requires a model to represent the components of a 
system so how the mutual activities of these components finally produce system behavior 
can be studied. In recent years, networks (graphs) have been the most prevailing data 
structure to construct disease models in systems biology studies [73-75].  This is because 
the most challenging diseases, like cancer and diabetes, usually arise from multiple factors 
and their complicated interactions [75-78]. These interactions can propagate the effect of a 
singular molecular perturbation to other parts of the system, eventually changing the 
system state [75, 78, 79]. Network/graph models in which nodes represent components 
and edges represent interactions is the most direct representation of the dynamics within a 
system. So network analysis becomes a very important part in systematic approaches.  
As we mentioned in previous sections, the revolutionary biotechnologies generate 
tons of heterogeneous data awaiting integrative analyses. And such analyses are necessary 
or even routine when systematic approaches are applied. In section below, I will identify 
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how this thesis can contribute to the integrative analysis and thus help to pave the way for 
prosperous applications of systematic approaches. 
 
1.3 General statement of problems 
 
High-throughput technologies in the post-genomic era such as microarray, ChIP-
chip, NGS, RNA-Seq, ChIP-Seq (see 1.2.1) have been driving the exponential growth of 
biological data (see 1.2.3). The enormous data reservoir has been filled by heterogeneous 
sources: genomics, transcriptomics, proteomics, interaction data, metabolic data and 
annotation data (see 1.2.3). Powerful technologies and abundant data provide biologists 
unprecedented opportunities to ask questions that can only be answered with a systematic 
and integrative view. For example, how do cells of different types arise from a 
homogeneous cell pool during development of an organism? To answer these questions, 
connections must be made between genes to gene expression and regulation/ interactions 
to determine how the components work together as a system.  With unprecedented 
opportunities come tremendous scientific and technological challenges such as developing 
methods and tools to analyze data, creating information systems to effectively handle data 
flow, and systematically integrating information to interpret data (see 1.2.2).  There are 
many angles to view these challenges and one of them is the biologist’s view.  Biologists 
would like to leverage heterogeneous big data for clues to answer their questions, yet 
methods and tools that can help them to implement this approach are relatively scarce. 
This problem could be read into three pieces in a divide-and-conquer philosophy. First, is it 
is necessary to have a model system (see 1.2.4) from which biologists can formulate their 
questions, collect data, and conduct data analysis. Second, biologist-friendly methods and 
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tools must be developed to leverage heterogeneous big data (see 1.2.3).  Third, methods 
and tools developed in one model system must be extended to other biological systems.  
All three points mentioned above are so general that exhaustive explorations of all 
of them are far beyond the scope of this thesis. However, a heuristic strategy can still be 
employed to approach this problem with full consideration to all three aspects. In other 
words, for this thesis it is feasible to focus on one model system, use it to ask appropriate 
questions, and more importantly, develop one or two information-leveraging methods or 
tools that work for, yet are not bound by, the investigation on this specific model system. So 
what kind of leveraging strategy is broad and intuitive enough to generate methods and 
tools that have a wide application?  For leveraging heterogeneous big data, integration is a 
must since different sources of information must be comprehensively utilized.  
Prioritization is also necessary to identify a focus in clues from a sea of data for further in-
depth research.  Methods and tools that help to integrate and prioritize heterogeneous big 
data would alleviate the need of leveraging heterogeneous big data and thus contribute to 
coping with the challenges imposed by high-throughput technologies and exponential 
growth of dataset size.  
In summary, this thesis will try to solve at least two problems: 
1. Conduct a heuristic exploration on a model system that is appropriate for asking 
questions that would be better answered by systematic and integrative approaches. 
2. Develop methods/tools that can integrate and prioritize large, heterogeneous 
datasets to facilitate a systems biology investigation. 
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1.4 Specific rationale and objectives 
 
Based on the general statement of problems, I provide a rationale to target three 
specific objectives as shown below. 
 
Rationale 1 
 We know cell fate determination in the developing vertebrate retina is dependent 
upon a number of gene interactions (see 1.5.1). We also know that the developing 
vertebrate retina is an ideal model system to study cell fate determination and 
differentiation (see 1.5.1). First, it is a multicellular tissue whose development is well 
characterized and within which the sequence of cell genesis is well documented. Second, 
the development and cell genesis of this tissue is largely conserved among vertebrates. 
Third, this tissue is highly accessible and is very amenable to in vivo hypothesis testing. The 
mouse retina is such an ideal model system that has long been studied. With the developing 
mouse retina, activities of gene networks that underlie the cell fate determination and 
differentiation would take place in well-characterized cells with known birthdates and 
known locations within the tissue. Also, the role of hypothesized gene candidates and 
network interactions in cell fate determination and differentiation can be readily assessed. 
Additionally, knowledge learned on this model system can be leveraged to study other 
vertebrate retinas. So the developing mouse retina is an excellent model that systematic 
and integrative approaches can be applied to. 
Retinogenesis is a developmental process during which different types of retinal 
cells arise from a pool of retina progenitor cells to form a functional retina. Many studies on 
this process have generated a reservoir of prior knowledge on essential genes to direct this 
process. These known essential genes mostly were discovered in small-scale gene-
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knockout studies and thus only cover tiny patches of the whole map [80, 81]. At the same 
time, studies employing high-throughput technologies are generating more and more data 
awaiting further exploration [82] (Only two examples are cited here [83, 84] due to the 
large volume of data). So utilizing prior knowledge to extract relevant information from 
ever-increasing amount of data is urgently needed. To utilize prior knowledge, it is 
important to consider it in an in-depth developmental context as well as to summarize it in 
a data form that can be readily used to guide further investigation. This is because it does 
not make any sense to explore the effect of genes on cellular fate choice without specifying 
developmental context such as when (developmental period) and where (location within 
tissue) the gene is expressed. More importantly, in a certain developmental context, how 
these genes work together to exert the overall effect must be summarized in a simplified 
form that even researchers outside this specific area can easily understand.  
 
Objective 1 
Based on the above rationale, the first objective of this thesis is to summarize prior 
knowledge on cell fate determination and differentiation of mouse retinal cells in a data 
form appropriate for systematic approaches and leverage the prior knowledge to 
heuristically search high-throughput data.  
 
Rationale 2 
For questions such as what is the molecular basis of cellular determination and 
differentiation in developing retina, identifying key genes and their interactions within a 
certain developmental context is the first and foremost job. While clues from small-scale 
studies may be summarized to help identify key genes and their interactions, the 
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overwhelming amount of data that comes from high-throughput screening platforms is far 
beyond the scope of a manual search. Biologists urgently need tools that can assist them in 
integrating information to extract the most useful results. For example, when faced with a 
large number of gene candidates generated from microarray or RNA-Seq, biologists would 
want to narrow down a long list of genes to identify the most promising candidates for 
more in-depth investigation.  In addition to the prioritization of gene candidates, 
integrating interactions among genes to construct a composite network is necessary to gain 
a bird’s eye view of known knowledge and grasp essential clues. Putative gene 
relationships can come from sources such as physical interactions identified by ChIP-chip/ 
ChIP-Seq and yeast two hybrid, genetic interactions identified by genetic array, genetic 
knock-out an knock-in experiments, and coexpressed interactions identified by expression 
profiling.  With these different sources of putative gene relationships, how could we 
integrate them for an even more reliable prediction on gene relationships for our biological 
questions? To approach this in a quantitative way would be difficult since these sources are 
across heterogeneous platforms and a quantitative measure that can be associated with a 
biological interpretation is tough to define.  To approach this problem in a qualitative way 
might be a good choice, yet a qualitative integration method and tool is absent.  
 
Objective 2 
From the rationale, I concluded it was necessary to develop a tool that helps 
prioritize candidate genes and their relationships by qualitative integration of data from 
heterogeneous sources for systematic investigation and it would be the second objective of 
this thesis. 
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Rationale 3 
The second objective aims to generate a tool that can qualitatively integrate 
heterogeneous information for prioritization of gene candidates and construction of 
networks of interest. When heterogeneous data are integrated to answer a biological 
question, it is more likely the data used are from the same organism. However, in some 
scenarios data from multiple organisms may be used. For example, comparing two or more 
organisms to detect conserved or divergent parts of the network of interest, or using 
closely related species as prior knowledge to leverage queries of the unknown in the 
organism of interest. Unlike intra-organism integration, inter-organism integration is quite 
complicated due to the fact that genes or proteins must be first matched or translated 
across organisms. An intuitive strategy is to use DNA or protein sequence homology as a 
bridge between organisms. However, a biological truth is one gene in one organism may 
have multiple homologous counterparts in another organism, and even worse two genes 
may share the same homologous counterparts. This is a major hurdle for application of 
network information since the across-genomes projections are based on multiple 
interacting genes instead of one individual gene. That gene correspondence between two 
genomes that is not one-to-one can dramatically affect the network topology, resulting in 
noise that may eclipse homologous relationships. So matching two genomes at the genome-
wide scale and  in a one gene to one gene fashion is highly desirable and a method and tool 
to solve this problem would largely contribute to integrating information across organisms.  
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Objective 3 
Based on the above rationale, the third objective of this thesis is to develop a 
method/tool that can quickly match across genomes in a one gene to one gene fashion at 
the genome-scale.  
 
 
1.5 Literature Review 
 
1.5.1 Cell fate determination and differentiation of mouse retina 
Multicellular organisms, as the name implies, have multiple cells as well as multiple 
cell types. For example, a human is a multicellular organism since it is composed of 
multiple cell types (skin cell, bone cell etc.). During the development of a multicellular 
organism, cells have to become specialized. For example, multiple cell types arise from a 
zygote (the initial cell formed when the egg and the sperm joined).  In developmental 
biology, determination means cells choose a particular fate, while differentiation follows 
determination to elaborate a cell fate-specific developmental program. To know how a cell 
is determined to a particular cell fate is a fundamental question in developmental biology 
and has huge potential in biomedical application. For example, pluripotent cells such as 
embryonic stem cells and induced pluripotent stem (iPS) cells, are unspecialized cells that 
can divide and renew themselves for long periods and give rise to specialized cell types. 
The underlying logic in stem cell therapy is to derive specialized cells that are desired for a 
certain kind of disease [85]. So knowing how a particular cell fate is determined will largely 
contribute to stem cell therapy in at least two ways: one is to induce a desired cell fate, and 
the other is to identify a marker profile that characterize and confirm the identity of a 
particular cell type. Previous studies showed that it is molecular regulation, especially 
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transcriptional regulation that integrates extracellular and intracellular signals to program 
cell fate [86]. So understanding cell fate determination requires identification of cell fate 
regulators and investigation of their underlying mechanisms. 
Several principles are inherently applied to the study of cell fate determination. 
First, the developmental stages need to be characterized for this model organism in order 
to know where and when the cell type of interest will appear. Second, manipulation of cells 
of interest and molecules of interest are allowed for this model organism in order to 
conduct experiments. Current methodology to study cell fate determination can still be 
divided into two categories even though they both share principles mentioned above. The 
first category of approaches usually employs the knock down, knock out and over-
expression of several candidate genes in a cell population of interest either in vivo or in 
vitro to see whether these candidate genes are regulators of this cell type. Studies falling 
into this category either use small-scale screen to investigate the roles of a few candidate 
genes in the proliferation, death, morphology and function of a cell population of interest, 
or use high-throughput technology to profile general expression patterns of genes in a cell 
or cell population of interest. The second category of approaches emerged in recent years 
and adopts a systems biology strategy that utilizes various types of data to construct, test 
and optimize a model by experimental, mathematical and computational methods. These 
models [87-89] tried to capture the essential dynamic of interaction of multiple genes that 
play a role in cell fate determination.  
The first and the second categories are complementary to each other and neither of 
them is dispensable. The first category lays down the foundation of, and will continue to 
exert important effect in, cell fate determination studies. But the lack of a systematic view 
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of the first category leaves a gap between various experimental data and a multi-dimension 
capture or modeling of a real situation, which drives the emergence of the second category. 
However, the second category is still in an exploratory stage in several ways:  the first is the 
lack of data on a specific model system. Systems biology takes advantage of a variety of 
information. However, without the focus on a specific model system, the information is 
diluted due to the dispersion of them among different model systems. Second, since cell 
fate determination may not only involve cell intrinsic programming but also cell extrinsic 
signals [90], the context is worth careful consideration: a context of diffused systems like 
the immune system or a context of cultured tissue system is different to that of a complex 
tissue. Third, specific data integration and model construction in systems biology approach 
are still in the exploratory stage [91-93].  
The vertebrate retina is a sheet structure composed of several neuronal layers, lying 
in the back of eye. Superficially it kind of functions like a film in the old-styled camera even 
it is actually more than that (which is beyond the scope of this thesis): the strikes of light on 
retina initiate a cascade of signals representing the visual information; and then the visual 
information received in the retina is relayed to the visual center of the brain [94].  The 
vertebrate retina consists of five well-defined layers. They are outer nuclear layer (ONL), 
outer plexiform layer (OPL), inner nuclear layer (INL), inner plexiform layer (IPL) and 
ganglion cell layer (GCL).  These layers consist of seven cell types: rod photoreceptor, cone 
photoreceptor, bipolar cell, ganglion cell, amacrine cell, horizontal cell and Muller glial cell 
[80]. The seven cell types that comprise the retina are derived from a common pool of 
retinal progenitor cells [95]. The sequence of retinal cell genesis is highly conserved among 
vertebrates,[96-100] following a general progression of retinal ganglion cells (RGCs), 
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horizontal cells (HCs), cone photoreceptors followed by amacrine cells (ACs), and 
subsequently bipolar cells (BCs), rod photoreceptors and Müller glial cells (MCs). 
The developing vertebrate retina is an excellent model to study cell fate 
determination. First, development of the retina is well characterized [101-103] and the 
sequence of cell genesis and differentiation is well documented. Thus, gene activities that 
underlie the fate determination in a particular retinal cell type will take place in known 
cells with known birthdates and known locations within the tissue. Second, the retina is 
highly accessible and is very amenable to in vivo hypothesis testing [104],  thus the role of 
hypothesized gene candidates and their interactions in cell fate can be readily assessed to 
some extent. Third, with relatively limited well-defined cell types, retina is a complex tissue 
and thus cell fate determination can be examined within the context of a complex tissue. 
Fourth, retina in several vertebrates such as mouse, frog, fish and chick are extensively 
studied and the conservation of cell types and cell genesis among vertebrates offers a great 
opportunity to consider cell fate determination in the perspective of evolution. The nice 
properties mentioned above makes the developing vertebrate retina a model system that 
systematic approaches can be applied to. 
 
1.5.2 Prioritization of candidates and integrations of networks 
Prioritization of candidate genes 
High-throughput technology is the method of scientific experimentation that allows 
the researcher to quickly conduct thousands and even millions of tests. Microarray is one of 
the most prominent high-throughput technologies, with either single array or two-color 
array to detect RNA expression levels of genes in a biological sample at the whole genome 
scale. Most microarray experiments are conducted to either obtain a differentially 
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expressed gene list between two conditions or profile the coexpression of genes across 
conditions. RNA-Seq [105] utilizes next generation sequencing technologies to sequence 
cDNA to get RNA content information. Other methods like SAGE [106, 107], CAGE [108, 
109] and MPSS [110]  also profile the RNA expression by sequencing. All these technologies 
have general goals similar to microarray analyses: to obtain differentially expressed genes 
among conditions of interest or coexpression gene clusters across conditions. Gene 
expression data generated by these high-throughput technologies are stored in publicly 
available databases like ArrayExpress and Gene Expression Omnibus. To identify 
differentially expressed genes, a procedure which includes normalizing array data [111], 
fitting a model to test parameters [112, 113]  and controlling  the false discovery rate[114] 
is already well established. A couple of tools [115, 116] to analyze microarray data are 
freely available on line, and statistical methods for RNA-seq are also emerging as next 
generation sequencing is increasingly used[22, 117].  While hundreds and even thousands 
of candidate genes now can be generated from a single high-throughput experiment, they 
are unlikely to get experimentally validated due to time and cost constraints. Thus it is 
imperative to identify the most potentially promising candidates through prioritization and 
ranking. Various ways [118-126] and tools [127-131] have been proposed to address this 
need and they are generally grouped into three categories. 
The underlying principle of the first and most significant category is to find genes 
that are most relevant to a particular phenotype, for example, a disease. This principle 
evolved from the utilization of GO and KEGG enrichment [132-135] to an integrating 
methodology that utilizes heterogeneous data sources.  These methods rank candidate 
genes by their similarities to the training data in data sources including published 
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literature, functional annotation ontology, signaling pathway, sequence, expression and 
interactions. Training data can be a set of seed genes involved in a certain biological 
process or the keyword describing this biological process. For many more specifics about 
these methods and tools (which are not very related to this thesis), we refer to the review 
by Tranchevent et al. [136]. While the similarity-based methods successfully utilize 
heterogeneous data sources and prior knowledge to rank candidates, they are also limited 
or biased by the training data and thus not sensitive to candidate genes that are from less 
well annotated biological processes or involved in cross talk between different pathways. 
Additionally, computational tools that implement these methods automatically query data 
source from pre-determined public databases and thus cannot be used in a case-specific 
way.  
The second category is the statistical ranking of candidate genes. This approach 
essentially seeks to separate systematic effect from random effect. That is, to make the top 
genes most enriched in true positive.  In a series of studies [120, 121, 137-139] that 
compared the performances of different gene ranking methods such as WAD (weighted 
average difference)[140], AD (average)[140], fold change (FC), rank products (RP)[141], 
moderated t statistic (modT)[113], significance analysis of microarrays (samT)[142], 
shrinkage t statistic (shrinkT)[143], and intensity based moderated t statistic (ibmT)[144], 
found that the fold change-based gene ranking methods work better in terms of 
reproducibility for differentially expressed genes. Particularly, the WAD, RP or ibmT 
statistical rankings had higher levels of sensitivity and specificity than other methods. 
In addition to high-throughput technologies, candidate genes can be obtained by 
many other ways, including generated from analyses like differentially correlated 
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genes[145], summarized from literature, or  as query results from databases or small-scale 
experiments.  Accordingly, methods to prioritize candidate genes are not limited to the 
major categories reviewed above. For example, Oti et al. employed a cross-species 
comparison strategy from the evolutionary angle and prioritized disease genes using gene 
coexpression conservation across distantly related species [119].  Thus, it is impossible to 
cover all kinds of candidate genes and prioritization methods here. But the point is, 
biologists currently are faced with a large number of candidate genes from heterogeneous 
sources and lists of prioritized candidate genes generated by various prioritization 
methods. Biologists greatly need tools that can help to integrate lists of candidate genes. 
 
Integration of networks 
Many biological questions require investigation of gene relationships, which require 
the generation of interaction data. There are generally three groups of interaction data. The 
first group is direct, physical interaction of two entities within a biological system. The 
most prominent interaction types include protein –protein interaction, protein –DNA 
interaction, and metabolic interaction between metabolites. Popular approaches to detect 
protein –protein interactions are yeast two hybrid, coIP/MAS and LUMIER [146]. DNA-
protein interactions can be assayed from small-scale experiments like Gel mobility shift, 
DNase Footprint and other footprinting methods, to high-throughput experiments such as 
ChIP-chip and ChIP-Seq. NMR spectroscope and MAS based techniques are used to profile 
metabolic interactions [147]. Interactions in the second group are usually inferred from 
various experimental data. They may foretell physical interactions between genes or reveal 
their shared biological roles. For example, positive and negative interactions from genetics 
experiments showed the direct or indirect regulatory effects among genes; co-expression 
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interactions reveal that some genes have similar expression pattern and thus more likely 
work together for the same task. Although interactions at this level are not physical, they 
have experimental evidence to support potential physical interactions. Interactions in the 
third group are predicted by computational/statistical model instead of experimental data. 
For example, the putative regulatory sequence motifs shared among genes may suggest 
these genes are co-regulated.  To properly interpret interactions at this level, the data used 
and the underlying assumptions of models should be carefully inspected. As discussed 
above, there is a huge amount of interaction data generated from heterogeneous sources. 
To make interaction data easily accessible, public databases such as MINT[148], 
BioGRID[149], IntAct[150] and etc. have been developed to store and query these data. In 
addition to these well-known databases, a lot of other databases that are more specific for 
certain purposes also store interaction data. 
Network construction and integration are sometimes interwoven together. For 
example, one may need to integrate interactions from heterogeneous sources to construct a 
network; one may also wish to integrate several well-constructed networks to compare 
reproducibility. So the two terms are used here interchangeably, with network construction 
emphasizing the way to put interaction data into a network, and network integration the 
way to deal with heterogeneous sources. As mentioned above, there are three levels of 
interaction data. Only interactions of the first level are generated by experiments. Thus, in 
the most common scenario, a network has to be derived from both experiments and other 
data sources. A lot of effort has been devoted to methods and tools of network construction 
and integration. 
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Current strategies mainly fall into four groups. The first group [151, 152] includes 
those that utilize correlation coefficients, Euclidean distances, and information theoretic 
scores such as the mutual information to describe the dependencies between genes 
(nodes). Take a coexpression network as an example.  Correlation coefficients of genes 
across several conditions are calculated and then genes are connected if their correlation 
coefficients pass a statistically reasonable cutoff value. Methods in this group have the 
advantage of simplicity and low computational costs and thus make the inference of large-
scale network easy to handle. But the drawbacks are twofold: 1) the network is determined 
by an arbitrary threshold. And 2) the network is static yet gene activities are quite dynamic 
across conditions being used. The second group [153, 154] uses differential equations to 
describe gene activities as a function of other genes and non-gene factors. By solving 
differential equations, the association of each gene with other genes and non-gene factors 
can be revealed. This group requires the specification of function and some certain 
constraints for function parameters. The third group is Boolean networks [155] in which 
nodes can be “on” and “off” and edges are represented by Boolean functions. To construct a 
Boolean network, continuous gene expression signals have to be transformed into binary 
data (“on” and “off”) and Boolean functions be inferred by various algorithms. While 
Boolean networks have inherent limitation since two states cannot adequately describe 
gene expression, they are dynamic, easy to interpret and very suitable for gene regulatory 
relations. The fourth group is Bayesian networks [156, 157] in which genes (nodes) are 
random variables associated with probability distributions and the relations among genes 
(edges) are described as conditional probabilities. Bayesian networks are very flexible at 
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integrating different types of data and prior knowledge. They can also be either static or 
dynamic up to the given data.  
As network construction strategies infer more and more networks from ever 
increasing number of data sets, network integration has become imperative, because 
researchers are faced with heterogeneous networks. Pioneering efforts have been devoted 
to the network integration from several aspects. The first is data exchange: incompatible 
format hampers the sharing of the interaction data stored across databases. BioPAX [158], 
a computable language that can represent various pathway and interaction data, 
established a standard syntax for this kind of information, largely facilitating the data 
exchange. Although several databases of interactions almost adopt BioPAX, text files are 
still the most popular ones among biologists.  This is because, on one hand, there is still a 
huge amount of interaction data not in BioPAX, such as interactions stored on personal 
webpages, databases oriented for specific purposes, or data generated from independent 
experiments. On the other hand, biologists who do not have programming skills or are 
unwilling to do unnecessary format-converting work would likely adopt the easily-
perceived text file. With more effort devoted to tools such as Sig2BioPAX, a command line 
JAVA program which converts text file to BioPAX format [159], text files can easily merge 
into the data exchange flow. The second is data collection: cPath [160] and Pathway 
Commons [161] can query and collect interactions by source (database) and interaction 
type from a list of databases.  While inter-database query and collection are almost 
automated for several significant databases, manual collection and editing are still 
unavoidable due to two reasons. The first reason inter-database mass-collection only 
covers a certain list of databases. Second, compared with collection within a specific 
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database, mass data collection loses some information (such as experimental system and 
etc.), which may be useful to by biologists. The third aspect of network integration is 
integration methods and tools: CABIN [162] enables the integration of interactions from 
multiple sources of evidence by assigning each source a weight based on the confidence in 
the evidence. GraphWeb [163] is a web server that allows the combination of multiple 
networks into a global network by specifying the values in edge and node settings. CABIN 
and GraphWeb assume that all edges in a source network have the same confidence in 
evidence and assign all the edges in the network the same score or weight. GeneMANIA 
[164, 165] allows more weighting strategies of interaction sources including query 
dependent weighting, GO-based weighting and equal weighting. GeneMANIA does excellent 
job when it comes to merging heterogeneous sources of data, user interface, and speed, but 
like CABIN and GraphWeb, some detailed information are lost due to the assumption that a 
source network is a homogeneous network. For example, all physical interactions are taken 
as the same in ignorance of different experimental evidence codes. 
Network visualization is almost imperative in network integration due to several 
reasons. First, compared with other data structures, networks (graphs) rely more on image 
representation to convey information. Second, visualization is expected to give viewers the 
insight that may not be possible without it. Third, interactive visualization helps users 
assemble the network. For these three reasons, we can see visualization is quite data-
oriented and study-specific. In addition, network visualization is coupled with network 
integration to some extent. For example, if the purpose is to merge large-size networks, 
visualization should be able to display a large-size network in an excellent layout that helps 
users to see the global features; if the purpose is to map across large-size networks to get a 
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single network with higher confidence, then in addition to the global layout, visualization 
should be able to distinguish the overlapping interactions. Generally, network size, 
interaction type and the needed analysis are the factors that fit the features of network 
visualization. A couple of network visualization tools are freely available now. For example, 
Cytoscape [166-168] is an influential network visualization platform, and its plug-ins 
render Cytoscape the ability to do various visual analyses of networks. VisANT [169-171] is 
a network visualization and analysis platform leaning towards the metagraph feature and 
gene set enrichment analysis. GenMAPP [172-174] focuses more on pathway analysis of 
high-throughput expression data. For other network and pathway visualization tools like 
Osprey [175], CellDesigner [176], BioLayout [177, 178], ProViz [179] and so on, each has 
its own set of  build-in features. If the reader is interested in these tools, we refer to the 
review by Gehlenborg et al. [180] 
 
1.5.3 Integration data across organisms 
Integration of knowledge or data across organisms is widely applied in functional 
studies and evolutionary studies, or a mix of both.  In functional studies, data integration is 
driven by the motive to leverage as much information as possible to study the function of 
one single gene or a set of genes. To name a few, functions of gene copies in several 
organisms are used to infer gene function in another organism [181]. Functional 
relationships of a set of genes are predicted by integrating high-throughput data form 
multiple organisms [182]. In evolutionary studies, it is necessary to incorporate knowledge 
from multiple organisms to study the evolutionary relationships at genome-level or gene-
level [183]. For example, copies of the same gene from multiple organisms are used to 
construct a phylogenetic tree that reveals evolutionary relationships between genes. In 
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some studies, evolutionary and functional insights are equally important. For example, 
orthologous gene sequences are utilized to identify common allelic sequences that have 
similar effect on phenotypic variation, helping develop functional marker across several 
plant species[184].  
Leaving aside different emphases of studies, the underlying logic of all examples 
listed above is the same. That is, DNA sequences encode RNA sequences and then proteins 
that are responsible for functions, so conserved DNA sequences encode common features 
of different organisms and likewise divergent DNA sequences reveal functional differences 
among them. So DNA /RNA / protein sequence homology is the key to any application that 
are across organisms. This means sequence alignment is very important for data 
integration across organisms. Many sequence alignment algorithms and software [55, 185-
192] have been developed to cater to a variety of needs such as pairwise sequence 
alignment , multiple sequence alignment, motif finding, short read sequence alignment and 
genomic analysis to identify splice site junction, introns and ncRNAs. For the need of 
integrating data across organisms, pairwise sequence alignment and multiple sequence 
alignment are most important since they are the first and foremost step to identify 
homologous relationships which serve like bridges between organisms.  
Even the underlying principle utilized in integration of knowledge across organisms 
is the same, specific strategies, methods and tools hinge on study emphases. In situations 
where function is the concern, sequence homology itself is more like a tool to leverage 
heterogeneous data of one organism in order to annotate that of another. For example, in 
tool like Blast2GO, to annotate the unknown genes, GO terms of its homologous genes are 
used and a Blast search of query sequence against NCBI database is how homology is used.  
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Similarly, a tool called IMP [193] constructed functional association networks from 
pathway annotations as well as GO terms of multiple model organisms to predict the 
function of query gene in any organism. More data sources [182, 194] such as microarray 
data and protein-protein interaction data are added into this category of methods and 
tools. In addition to functional prediction, data of multiple species are also used to 
prioritize candidate genes [195, 196] and construct biological networks [197]. It is worth 
noting here homologous relationships can be further divided into homologs, orthologs and 
paralogs [198]. Homolog is a general term that refers to genes that share significant 
sequence homology. Orthologs are homologs that descend from common ancestral 
sequence that are then separated by speciation event, while paralogs are homologs that 
stem from gene duplications within the genome. Since paralogous genes may or may not 
share more sequence similarity than orthologous genes, it is hard to tell them from each 
other by pure sequence homology. The term ortholog is often mis-used or loosely used in 
non-evolutionary studies to actually mean homologs that share very high sequence 
similarity. But to really name orthologous relationships, the construction of phylogenetic 
tree is necessary. So unlike that in functional studies, the way homology is used becomes 
quite important since it must adapt to different purposes such as phylogenetic analysis, 
detection and characterization of duplication and recombination events, estimation of 
selection pressures and population genetic inferences. On the contrary to heterogeneous 
data used in functional studies, evolutionary studies mostly use sequence data.  
 In this chapter, I summarized two general problems from the overview of 
background. To approach the two general problems within the scope of this thesis, three 
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specific objectives were identified and rationales provided. Chapter 2, 3 and 4 describe 
how the three specific objectives were achieved.  
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CHAPTER 2. Mouse Retinal Development: 
a Dark Horse Model for Systems Biology Research 
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Abstract 
The developing retina is an excellent model to study cellular fate determination and 
differentiation in the context of a complex tissue. Over the last decade, many basic 
principles and key genes that underlie these processes have been experimentally identified.  
In this review, we construct network models to summarize known gene interactions that 
underlie determination and fundamentally affect differentiation of each retinal cell type.  
These networks can act as a scaffold to assemble subsequent discoveries.  In addition these 
summary networks provide a rational segue to systems biology approaches necessary to 
understand the many events leading to appropriate cellular determination and 
differentiation in the developing retina and other complex tissues. 
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Introduction 
Multicellular organisms are made of tissues with multiple specialized cell types.  
Understanding the determination and differentiation of heterogeneous cell types within 
the context of complex tissues is fundamental to many areas of biology.  This knowledge 
will have widespread application in treatment of developmental disorders and disease 
states such as cancer and will be critical for successful bioengineering and transplantation 
of tissue types to replace damaged or degenerate structures.  The determination and 
differentiation of a given cell within a tissue is the culmination of the expression of many 
gene products and their subsequent intra- and intercellular signaling events.  To address 
the challenge of understanding cell fate determination and differentiation we must adopt a 
broad systems biology approach to adequately take into account the activities of large 
numbers of genes and signaling pathways.   
One emerging systems-based strategy to analyze and integrate large datasets is to 
generate network models, in which genes or proteins are represented by nodes and their 
relationships by edges in the graph (network).  However, most large expression datasets 
are too sparse to infer high statistical confidence gene relationships which are based on 
estimate of a covariance matrix [199]. In addition, the networks generated de novo are 
often large, and do not facilitate prioritization of candidate genes and gene relationships for 
hypothesis based validation.  To address this problem, we have previously described a 
heuristic approach that uses a seed network to summarize prior knowledge of a small part 
of the gene network involved in cellular development [200, 201].  The seed network can 
then be used to query large datasets in order to identify additional molecules with putative 
relationships to seed genes.  These candidate molecules can then be used to expand the 
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network and are the basis for generating testable hypotheses to validate their functional 
role. 
Cell fate determination and differentiation in the vertebrate retina provides many 
opportunities to generate and utilize systems-based tools and approaches to understand 
development of cells within complex tissues. First, development of the retina is well-
characterized [101-103] and the sequence of cell genesis and differentiation is well-
documented and largely conserved among vertebrates [96-100]. Thus, activity of gene 
networks that underlie the fate determination and differentiation in a particular retinal cell 
type will take place in known cells with known birthdates and known locations within the 
tissue. Second, the retina is highly accessible and is very amenable to in vivo hypothesis 
testing [104], thus the role of hypothesized gene candidates and network interactions in 
cell fate determination and differentiation can be readily assessed. Third, we can build on 
the foundational system-based approaches developed through the study of single cell 
organisms like yeast [202], diffuse systems like the immune system [203], or cultured 
tissue systems [87],  and extend these methods to examine the development of more 
complex tissues that comprise living organisms. 
Here we review what is presently known about the genetic networks that underlie 
cell fate determination and differentiation in the developing retina.  The developing retina 
is an extensively reviewed [80, 81, 95, 204, 205] system regarding cell fate determination 
during retinogenesis, but a summary of literature-curated gene networks underlying 
differentiation of each retinal cell type has not been previously presented.  In order to 
demonstrate its potential as a model to study determination and differentiation of multiple 
cell types within the context of a complex tissue, we have assembled seed networks to 
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summarize what is known about the genes and their relationships that underlie cell fate 
determination and largely influence the differentiation of each of the basic retinal cell 
types. 
 
Results 
Retinal Cell types  
The mature mouse retina is composed of seven basic cell types, six neuronal and 
one glial (Figure 2.1). While this review focuses on only the differentiation of the basic cell 
types, many retinal cells can be further subdivided morphologically, biochemically and 
functionally [206-216]. Photoreceptors (rods and cones) reside in the outer nuclear layer 
(ONL) and are responsible for phototransduction and necessary for vision [217]. 
Photoreceptors synapse with bipolar cells, neurons that reside in the inner nuclear layer 
(INL).  Bipolar cells relay visual stimulus to retinal ganglion cells in the ganglion cell layer 
either directly or indirectly via amacrine cells, which also reside in the INL.  Other cells 
present in the INL are horizontal cells, which mediate lateral interactions between 
photoreceptors and Müller glia that play a critical role in retinal homeostasis [218]. Axons 
of the retinal ganglion cells project into the visual centers in the brain, thereby relaying the 
visual information detected by the retina. While appropriate processing of visual stimuli 
requires the function of all retinal cell types, most blinding retinal diseases are the result of 
the degeneration of photoreceptors or ganglion cells [219, 220]. Interestingly, the seven 
cell types that comprise the retina are derived from a common pool of retinal progenitor 
cells [95]. Thus, the developing retina provides a relatively simple, yet elegant system to 
study the generation and maturation of a complex tissue. We know that the cell fate 
decisions made by retinal progenitor cells are governed by an intrinsic genetic program 
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that determines their response to extrinsic cues from their environment [80, 95]. The 
sequence of retinal cell genesis is highly conserved in vertebrates [97, 100, 221-224], 
following a general progression of retinal ganglion cells (RGCs), horizontal cells (HCs), cone 
photoreceptors followed by amacrine cells (ACs), and subsequently bipolar cells (BCs), rod 
photoreceptors and Müller glial cells (MCs) (Figure 2.2). Based on this general progression 
of birth order, retinal cell types can be divided into cohorts of early-born cells which 
include ganglion cells and cone photoreceptors, and late-born cells which include rod 
photoreceptors, bipolar cells and Müller glia [97]. 
 
Gene Families that Underlie the Specification of Retinal Cell Types 
There are a number of genes that are well known to act in the specification of 
and/or largely influence the differentiation of retinal cells. They compose a regulatory 
network that can integrate extrinsic information through signaling pathways like Notch, as 
well as implement intrinsic programming via transcription factors, many of which can be 
grouped into the basic helix loop helix (bHLH) gene family and the homeobox gene family.  
The family of basic helix loop helix (bHLH) genes is characterized by an α helix-loop-
α helix structural motif. The bHLH genes Mash1, Math3, NeuroD, Math5 and Ngn2 regulate 
each other to specify neuronal types in developing retina [205, 225], while Ptf1a [226, 
227], Bhlhb4 [228] and Bhlhb5[229] have roles in the development of more specific retinal 
cell types or subtypes. Other family members such as Hes1 and Hes5 work as effectors of 
Notch signaling. These bHLH genes interact with several other genes including Pax, CVC, 
POU, Lim, Sox and Dlx. The Pax gene subfamily has critical roles in embryogenesis [230] 
and Pax6 functions as an early regulatory gene in the development of eye [231]. In contrast, 
the CVC homeodomain subfamily members Vsx1 and Chx10 have more specific roles in 
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retinogenesis across vertebrate species like mouse [232, 233], chicken [234] and fish [235, 
236]. The POU homeodomain subfamily members have a variety of functions related to 
neural development [237], and genes Brn3b, Brn3c and Brn3a are important in the 
development of retinal ganglion cells . The LIM homeodomain gene subfamily are involved 
in neural patterning [238] with Isl1 and Lim1 playing crucial roles in retinal development. 
The Sox subfamily genes [239] and Dlx genes [240] are indispensable in many aspects of 
development including neurogenesis,  and Sox2 [241], Sox4 [242] , Sox8 [243], Sox9 [243], 
Sox11 [242]are implicated in retinogenesis.  Like the bHLH genes, some homeobox genes 
like Vsx1 [244, 245], Barhl2 [246] and Irx5 [247] appear to specify retinal cell subtypes.  
Together these genes (see Appendix A. Supplementary Information) work in concert to 
specify cell fate in the developing retina.   
Using a scaffold of these gene family members, we developed a seed network to 
summarize key gene relationships that govern the development of each of the retinal cell 
types in mouse retina. These seed networks are based on published studies that have 
demonstrated a role for the seed genes in the determination and differentiation of retinal 
cell types via either loss of function experiments[226, 248-255] gain of function 
experiments[241, 256] or transcriptional regulation experiments[243, 257]. Genes 
involved in the specification of multiple retinal cell types (see Appendix A. Supplementary 
Information) are not always included, in a given seed network due to the lack of strong 
evidence they interact with other essential genes in the seed network specifying a 
particular cell type.  These seed networks can be used in two complimentary ways: 1) to 
design database queries to identify additional key molecules for cell-specific development, 
2) to assemble a comprehensive summary of known gene relationships and identify key 
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decision points in cell-specific specification that may be important regulatory targets for 
future application. 
 
Müller Glial Cells 
The gene relationships that underlie Müller glia determination and differentiation 
are summarized in the seed network in Figure 2.3.  Müller glia are the only glial cells to 
arise from the retinal progenitor cell population.  Thus, the factors which influence the 
progenitor cell choice between gliogenesis and neurogensis are critical for the creation of 
these cells. Previous work has demonstrated that Notch signaling plays a major role in the 
choice between neural and glial cell fate [258]. Notch is a transmembrane receptor that 
functions at the cell surface to both receive extracellular signals and to regulate gene 
expression in the nucleus. Notch signaling is widely used to control developmental 
processes in many animal species [259]. In the developing retina, the Notch pathway is 
implicated in the control of progenitor cell proliferation and apoptosis, as well as the 
multipotency of progenitor cells [260]. In addition to its role in maintaining the 
undifferentiated and proliferative state of retinal progenitor cells (RPCs), Notch also seems 
to regulate the neuronal versus glial cell fate choice by inhibiting the photoreceptor cell 
fate in mouse retina [261, 262]. 
As essential effectors of Notch signaling [263], bHLH genes Hes1 and Hes5 have 
partly overlapping but distinct roles in Müller cell determination and differentiation. Both 
Hes1 and Hes5 are thought to repress expression of neuronal bHLH genes [205]. However, 
their specific target genes appear to be different, since Hes1 maintains the progenitors and 
inhibits both neuronal and glial differentiation, whereas Hes5 cooperatively regulates 
maintenance of progenitors but promotes the glial cell fate [248, 249]. Specifically, Hes1 is 
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known to inhibit the proneuronal gene Mash1 [264] and thus promotes glial cell 
determination. Consistent with their different effects, both Hes1 and Hes5 are expressed in 
undifferentiated cells while Hes5 is also expressed in differentiating Müller glial cells.  
The homeobox gene, Rax, promotes the glial cell fate choice, potentially via 
activation of promoters of Notch1 and Hes1 [258]. The SRY box genes Sox8 and Sox9 have 
also been implicated in the specification of Müller glial cells [243, 265], though neither of 
them alone is sufficient to induce Müller glial cell differentiation. Notch signaling regulates 
Sox8 and Sox9 transcription, though it does not appear to be through its activation of Hes1 
and Hes5 [243]. 
 
Retinal Ganglion Cells 
The gene relationships that underlie retinal ganglion cell determination and 
differentiation are summarized in the seed network in Figure 2.4.  The bHLH gene Math5 
plays a critical role in retinal ganglion cell (RGC) development. The targeted deletion of 
Math5 results in the loss of more than 80% of RGCs [251], and a cell fate shift to other 
retinal cell types [251, 266, 267]. It seems that Math5 underlies RGC differentiation in two 
ways. First, Math5 is very important to activate a downstream transcriptional network that 
controls ganglion cell differentiation and development [268, 269]. Second, Math5 
suppresses other bHLH proneuronal genes such as Math3, NeuroD and Ngn2 that are 
involved in the adoption of other retinal cell fates [267, 269]. The available evidence 
suggests that Math5 is directly regulated by Pax6 [270, 271]. Downstream of Math5, Brn3b 
and Isl-1 are known to play critical roles in ganglion cell differentiation [251, 272, 273]. 
Brn3b, a POU subfamily gene, while not required for the initial commitment of RGC fate, is 
essential for early retinal ganglion cell differentiation [250, 274]. Homozygous disruption 
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of Brn3b leads to a selective loss of 70% RGCs [250] suggesting not all RGC differentiation 
is dependent on Brn3b [275]. Consistent with this, it is hypothesized that Brn3b regulates 
genes important for formation of RGC axons and axon path-finding [274, 276]. In addition 
to loss of Brn3b, deletion of the Lim family gene Isl-1 also causes a marked reduction in the 
number of ganglion cells [252]. Recent studies indicate that both Isl-1 and Brn3b regulate 
genes such as Eomes and Shh [272, 273]. Eomes is a T-box transcription factor, now known 
as a direct target of Brn3b and required for RGCs and optic nerve development [277]. Other 
Brn3b-related genes are also found to contribute to ganglion cell development.   For 
example, the zinc finger protein Wt1, acts upstream of Brn3b, and plays a role in the 
development of RGCs [278, 279]. Barhl2 functions downstream of Brn3b to regulate the 
maturation and survival of RGCs [246]. Math5 and Brn3b are essential for ganglion cell 
determination. In addition here are other Brn3b dependent-genes [257], Math5-dependent 
genes [269], and genes identified in RGC single cell expression studies [280]. However, the 
relationships of these genes to the network described here are not yet understood and 
were not included in our seed network.   
 
Bipolar Cells  
Compared to other retinal cell types, data supporting the relationships among genes 
essential for bipolar cells specification and differentiation are relatively sparse; however, 
the genes with key regulatory roles in bipolar cells determination and differentiation are 
summarized in Figure 2.5. The bHLH gene Mash 1 plays a pivotal role in bipolar cell 
differentiation. In both rat and mouse, the onset of Mash1 expression most closely 
correlates with the appearance of bipolar cells and Müller glia [281, 282]. In Mash1 -/- 
retinal explants, the differentiation of all late born retinal cells (bipolar cells, rod 
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photoreceptors and Müller glia) was delayed, and the number of the mature bipolar cells 
was significantly reduced, though the number of vimentin-positive cells (likely Müller glial 
cells) was increased [283]. Additionally, Mash1 is expressed by a subset (10-30%, 
depending on age) of the total proliferating progenitor cells, providing a molecular maker 
of heterogeneity among retinal progenitor cells (RPCs) [282]. Together, this evidence 
suggests that Mash1 plays a role in the commitment and/or differentiation of late born 
retinal cells, particularly bipolar cells. 
Mash1 and Math3 are co-expressed in various regions of CNS suggesting these genes 
may have some functional redundancy [254]. Interestingly, the Xenopus homolog of Math3, 
Ath3, was shown to directly convert non-neuronal or undifferentiated cells to a neural fate 
[284], though the phenotype of Math3 (-/-) mice suggests Math3 is not essential for 
neuronal commitment [254]. However, in Math3 (-/-)-Mash1 (-/-) mice, in regions where 
the two genes are normally co-expressed, neuronal fate is blocked at the neural precursor 
stage and cells that normally differentiate into neurons adopted the glial fate. The retinas in 
these animals lack bipolar cells and have a significantly increased population of Müller glia 
[254]. It has been shown that Math3 and Mash1 are expressed by differentiating bipolar 
cells in the retina [282, 284]. However, misexpression of Mash1 or Math3 does not promote 
bipolar cell generation, rather it inhibits Müller gliogenesis[285].   Taken together these 
studies suggest that Mash1, with the cooperation of Math3, prevents gliogenesis in the 
developing retina and contributes significantly, but not entirely, to the specification of the 
bipolar cell fate.  
The expression of the homeobox gene Chx10 is also integral to bipolar cell fate. 
Chx10 is restricted to the inner nuclear layer (INL) in the mature retina, though in the 
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developing mouse eye, the Chx10 transcript is confined to the anterior optic vesicle and all 
neuroblasts of the optic cup [286]. Loss of Chx10 results in reduced proliferation of retinal 
progenitors and a specific absence of differentiated bipolar cells [255]. Misexpression of 
Chx10 induces generation of inner nuclear layer cells [285], while misexpression of Mash1 
or Math3 together with Chx10 increases the number of mature bipolar cells while 
decreasing the mature Müller glial cell number [285]. Thus, it is proposed that Chx10 
confers the specific inner nuclear layer identity to retinal neurons while bHLH genes such 
as Mash1 and Math3 subsequently specify the bipolar cell fate [285]. In addition, Chx10 
promotes bipolar cell fate determination by inhibiting photoreceptor specification, 
presumably by acting downstream of Otx2 or other Otx genes [287]. Otx2 subcellular 
localization is hypothesized to play a role in the rod versus bipolar cell fate choice [288]. In 
the retina of a postnatal, bipolar-cell-specific-Otx2 conditional knockout mouse the 
expression of mature bipolar cell markers is significantly down-regulated [289], 
demonstrating its importance in bipolar cell differentiation.  
 
Amacrine Cells 
The gene relationships that underlie amacrine cell determination and differentiation 
are summarized in the seed network in Figure 2.6. For amacrine cell specification, the 
bHLH gene Math3 cooperates with another bHLH gene, NeuroD, and amacrine cells are 
completely missing in Math3-NeuroD double mutant retinas. The cells in the double 
knockout retinas that fail to differentiate into amacrine cells adopt both ganglion and 
Müller glial cell fates.  However, while these genes are necessary for amacrine cell fate 
determination, they are not sufficient; misexpression of either Math3 or NeuroD alone 
cannot induce amacrine cell genesis [256].  
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In the Pax6-knockout mouse retina, the retinal progenitor cells become totally 
restricted to an amacrine cell fate [270]. While misexpression of Pax6, Math3 or NeuroD 
alone does not induce amacrine genesis, the misexpression of a combination of bHLH genes 
Math3 or NeuroD with homeobox genes Pax6 or Six3 (the transcription of which is 
independent of Pax6 [290]) does promote amacrine cell genesis [256]. Furthermore, 
misexpression of Pax6 with only Math3 results in the production of amacrine cells and 
horizontal cells, while the combination of Pax6 and NeuroD predominantly increases only 
the number of amacrine cells, suggesting that when expressed with Pax6, NeuroD is more 
specific for amacrine cell differentiation than Math3 [256]. The homeobox gene, Sox2, is 
expressed in a subset of amacrine cells and misexpression of Sox2 results in a dramatic 
increase of amacrine cells in INL. Experimental evidence indicates that Sox2 
transcriptionally induces Pax6 and may also induce NeuroD [241]. Taking all these data 
into account, it appears that Sox2 functions upstream of Pax6 and NeuroD to 
affect/promote amacrine cell fate. 
The expression of the forkhead gene family member Foxn4 in mouse retina 
correlates closely with the birth date of amacrine cells and misexpression of Foxn4 
promotes amacrine cell genesis [253]. Further, Foxn4-null mice exhibit a significant 
decrease in amacrine cells and a complete loss of horizontal cells [253]. The effect of Foxn4 
on amacrine cell differentiation may be via activation upstream of NeuroD and Math3 
signaling, since in Foxn4-/- retinas there is a marked downregulation of NeuroD and Math3 
with no observable alteration in Math5, Ngn2, Chx10 or Pax6 expression [253]. 
Downstream of Foxn4 is Ptf1a[291] Lineage tracing reveals that Ptf1a expression in the 
developing mouse retina marks the horizontal and amacrine cell precursors [227]. Loss of 
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Ptf1a affects the differentiation of a small population of amacrine cells and the entire 
population of horizontal cells. While Foxn4 may influence amacrine cell differentiation via 
NeuroD and Math3, Ptf1a does not appear to work in this way as in the Ptf1a-null retina 
expression of the two genes was unaffected [226, 227]. 
 
Horizontal Cells 
The gene relationships that underlie horizontal cell determination and 
differentiation are summarized in the seed network in Figure 2.7. It appears that amacrine 
(Fig. 6) and horizontal (Fig. 7) cell fates are linked as they share several key regulatory 
genes including Foxn4, Ptf1a, Math3, and Pax6 (Figs. 6 and 7). As previously mentioned, 
misexpression of Pax6 with Math3 results in an increase of both horizontal cells and 
amacrine cells, though the effect on horizontal cell genesis is greater (14% increase) than 
the effect on amacrine cell genesis (7% increase) [256]. At the same time, deletion of Foxn4 
results in complete loss of horizontal cells, presumably via the downregulation of Math3 
[253]. 
Prox1, the Prospero-related homeobox 1, is also important for horizontal cell 
differentiation. Prox1 is expressed in, and is required for efficient cell cycle exit for, early 
RPCs (but not in late RPCs) [292]. Prox1-null retinas exhibit a complete loss of horizontal 
cells and the misexpression of Prox1 results in the production of horizontal cells [292, 
293]. Considering the fact that there is a lack of Prox1 expression in Foxn4-null retina and a 
downregulation of Prox1 in Ptf1a-null retina [226, 253], Prox1 seems to promote 
horizontal cell fate by acting downstream of the Foxn4-Ptf1a axis.  Downstream of Foxn4-
Ptf1a-Prox1 is another essential gene, Lim1 [291]. Lim1 is required for specific 
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morphogenesis of horizontal cells in chick retina [294]. In mouse retina, Lim1 is essential 
to instruct the differentiation and migration of horizontal cells to the correct laminar 
position [295, 296].  
 
Cone and Rod Photoreceptors 
Both cones and rods employ phototransduction, a process that captures and 
converts photons of light to an electrical signal; however, each cell type expresses a 
particular visual protein (opsin) to absorb a specific portion of the light spectrum. In mice, 
cones express either a S-opsin (short wavelength sensitive) or a M-opsin (middle 
wavelength sensitive) while rods express rhodopsin.  Interestingly, both rod and cone 
photoreceptors share several key genes essential for cell fate specification and 
differentiation. Thus, the relationships of genes underlying the differentiation of cones and 
rods are shown together in a single network (Figure 2.8). 
NeuroD is the only bHLH gene known to be essential for photoreceptor 
differentiation. NeuroD is expressed in developing photoreceptors and is maintained in a 
subset of mature photoreceptors in the adult mouse retina [297, 298]. In the NeuroD-null 
retina, the number of rods is reduced, while the number of the bipolar cells is increased in a 
dose-dependent fashion [297]. Misexpression of NeuroD not only blocks gliogenesis, but 
also favors rod photoreceptor differentiation while reducing bipolar cell differenation 
[297]. NeuroD is also necessary for sustained expression of TRβ2, an essential gene for 
cone photoreceptor development [298].  
Photoreceptor cell types are generated by common activity of genes like Crx (Cone 
rod homeobox), Nrl (neural retina leucine zipper), and Nr2e3 where the expression of one 
gene promotes rods and suppress cones. For example, Crx is expressed early in the 
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developing retina, and is predominantly expressed in photoreceptors in mature retina 
[299]. Crx transactivates the Rhodopsin promoter and acts synergistically with Nrl to drive 
rhodopsin expression in rods [299]. Crx also activates cone opsins [300, 301]. Two genes 
are known to suppress Crx function Ataxin-7 [302, 303] and BAF [304], both contribute to 
photoreceptor degenerative disease. Otx2, a member of Otx homeobox gene family, 
transactivates Crx [305] and misexpression of Otx2 directs retinal progenitor cells towards 
photoreceptor fate but Crx does not [305].  
Nrl is a basic motif –leucine zipper transcription factor preferentially expressed in 
rod photoreceptors [306, 307], which positively regulates rhodopsin [308, 309]. In the Nrl-
/- mouse retina, cone-like photoreceptor cells are clearly different from WT rods and 
cones, revealing a functional transformation from rods to S-cones [310, 311]. From these 
results, it is inferred that Nrl modulates rod-specific genes as well as inhibits S-cone 
differentiation through the activation of Nr2e3 [311, 312]. Nr2e3 expression is restricted to 
photoreceptor cells. It is a ligand-dependent transcription factor that requires itself for the 
repression of its own transcription [313, 314]. Mutation of Nr2e3 causes enhanced S cone 
syndrome (ESCS) [315], a retinal degenerative disease in humans that results in an 
abundance of short-wavelength sensitively cones (S cones) at the expense of rod 
photoreceptors [316]. It is hypothesized that when photoreceptors are first generated the 
defective Nr2e3 cannot prevent a ‘default’ shift of rod progenitors to an S-cone fate, 
producing a large number of S-cones and an absence of rods [317]. This is supported by the 
fact that Nr2e3 acts as a repressor of cone-specific genes in rods [318], and directly 
interacts with Crx to enhance rhodopsin and repress cone opsins [319]. 
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In addition to upstream genes including Otx2, Crx, Nrl and Nr2e3 as well as 
photoreceptor-specific genes like rhodopsin, S-opsin and M-opsin, retinoid receptors are 
indispensible for appropriate photoreceptor differentiation. Retinoid receptors belong to a 
steroid receptor superfamily of proteins that serve as ligand-dependent transcription 
factors. Retinoic acid (RA) plays its role in transcription through retinoic acid receptors 
(RARs) and retinoid X receptors (RXRs). 9-cis RA binds to and transactivates both RXRs 
and RARs [320]. In addition, 9-cis RA directs progenitor cells to the rod cell fate through 
activation of members of the steroid/thyroid superfamily of receptors [321]. Another 
effector of this family, thyroid hormone (TH), is found to induce progenitor cells to 
differentiate into cones in embryonic rat retinal cultures [322]. Many effects of TH are 
mediated by TH receptors (TRs) [323]. The most important TR in retina development is 
TRβ2. TRβ2 is expressed in the outer nuclear layer of the embryonic retina [324, 325]. The 
mouse retina has an opposing S-cone (greater expression ventrally) and M- cone 
(expressed more dorsally) distribution. Deletion of TRβ2 in mice causes the selective loss 
of M-cones and a concomitant increase in S-opsin immunoreactive cones, disturbing the 
gradient of an opposing S- (ventral) and M- cone (dorsal) distribution [326]. TH is also 
required to inhibit S-opsin and activate M-opsin expression [327]. Other studies confirm 
that thyroid hormone action is required for normal cone opsin expression during mouse 
retinal development [328, 329]. RXRγ cooperates with TRβ2 to suppress S-opsin in all 
immature cones and in dorsal cones of the mature retina though it is not necessary for M-
opsin regulation [330]. Finally, RXRα acts in synergy with Crx to activate many cone-
specific genes [331]. 
 
50 
 
Identification of experimentally-determined gene relationships in a high throughput gene 
expression dataset 
The gene relationships in the seed networks described above are supported by 
experimental evidence and thus have been validated in the narrow sense by identifying 
direct or indirect interactions between two genes under particular experimental 
conditions. The next step to identify the ‘system’ of genes that work together to influence 
cell-specific determination and differentiation will require the use of large gene expression 
datasets and potentially additional dataset types such as protein-protein interaction 
datasets, ChIP-Chip datasets, datasets from animals with specific mutations, etc. We have 
previously demonstrated the successful application of literature-derived seed-networks to 
query high-throughput gene expression datasets [200, 201]. One motivation for this review 
article was to assemble the available experimental evidence in a way that it might be 
readily applied to future studies of other cell types, and perhaps to even guide the 
experimental design processes that underlie the generation of new datasets. 
An implicit assumption when using large gene expression datasets is that legitimate 
gene relationships will be discoverable by identifying a correlation of expression between 
them. An important question, then is, are known experimentally-determined gene 
relationships identifiable in large gene expression datasets as high correlation coefficients? 
We used the seed-network that describes photoreceptor differentiation (Figure 2.8) to 
address this question.   
Using previously published data collected from developing rod photoreceptors 
isolated from the retina at E16, P0, P2, P6 and P10 [332], we calculated the correlation 
coefficients between all pairs of genes (edges) present in the seed network (Table 2.1). In 
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the photoreceptor seed-network, there were 13 genes and 17 edges (relationships) 
between them. Two genes (BAF and 9-cis-RA) were not present in the dataset, which left 
15 edges to identify. Seven of the 15 edges were recognized as high correlation coefficients 
(>0.85) and an additional three of the 15 edges were supported with weaker correlation 
coefficients (>0.45).   
Thus, two-thirds of the seed-network relationships are present in the dataset and 
nearly half of the seed-network relationships are strongly correlated. Encouragingly, our 
result suggests that a significant number of legitimate gene relationships can be discovered 
using gene expression data.  Previously, we have used seed networks to discover new 
candidate genes by focusing on genes that were correlated with multiple seed-network 
genes [200, 201]. Ultimately, it appears that it will require a combination of datasets and 
approaches to describe the entire gene network that underlies cell fate determination and 
differentiation. 
 
Summary  
The seed networks presented here can be the basis for queries of high throughput 
datasets to identify larger, more comprehensive networks that participate in cellular fate 
specification and differentiation in the developing mouse retina. In addition to 
summarizing prior knowledge of these processes, seed networks can also be the basis for 
comparative studies between tissue types within a species or between diverged organisms 
in order to identify genetic pathways that are conserved through development and 
evolution [201, 333-335]. While a more generalized gene-by-gene comparative approach 
has been effective in identifying orthologs that may play a role in a complex process or a 
disease state in different organisms [336-339], it is the conservation of not only the gene, 
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but of its relationships to other genes in a network, that dramatically increases the 
likelihood that the gene, in fact, functions in similar way.  Being able to include relational 
data is one advantage of the seed network approach over more generalized comparative 
studies. The effectiveness of a cross-species seed network approach has been 
demonstrated elsewhere [201, 334]. 
These seed networks were constructed to help demonstrate the potential of the 
developing vertebrate retina as a model system for the development and evaluation of 
systems based approaches.  In addition to its characteristic organization and 
developmental time course, there is a significant amount of high throughput data that has 
been collected from the developing retina [340-344], and single cells from the developing 
retina [280, 332, 345, 346]. Because of its characteristic organization during development, 
candidate molecules that are generated using systems based approaches can be rapidly, 
albeit cursorily, evaluated based on in situ spatial and temporal expression [201, 347]. 
Finally, due to its accessibility, candidates can be functionally evaluated in developing 
retinas using in vivo electroporation to either drive overexpression or knockdown 
expression of candidate molecules [348]. 
Networks and network representation of processes have an important role in the 
implementation of systems based approaches and the analysis of large datasets and 
complex processes. Demonstrating the ability of these seed networks to effectively focus 
the generation of hypotheses from high throughput data sets would significantly advance 
the discoveries that depend upon this type of data. In addition, we have also demonstrated 
that seed networks are an effective way to do comparative analysis of retinal development 
and use knowledge of one model system to drive discovery in another [201]. The use of 
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seed networks to identify conserved networks that act in similar ways (as opposed to 
conserved genes) will be tremendously useful in the extrapolation of discovery in one 
model system to another. Thus, development of systems based approaches to investigate 
cell fate determination in the developing mouse retina will not only lead to important 
discoveries in the developing retina, but strategies that can be broadly generalized to 
address many biological questions.  
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Figure 2.1.  The retinal cell types in the adult mouse retina. The adult mouse retina is 
comprised of three cellular layers separated by two synaptic layers. Rod and cone 
photoreceptors reside in the outer nuclear layer (ONL), and form synaptic contacts in the 
outer plexiform layer (OPL) with horizontal cells and bipolar cells, both of which reside in 
the inner nuclear layer (INL).  In addition, amacrine cells and the cell bodies of Müller glia 
are found in the INL. Synaptic contacts between bipolar cells, amacrine cells and ganglion 
cells are present in the inner plexiform layer (IPL) and ganglion cells reside in the 
innermost cellular layer, the ganglion cell layer. 
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Figure 2.2.  Time course of cell genesis in the developing mouse retina. Retinal cell types 
are listed on the Y-axis, developmental time on the X-axis. Birth of the animal is indicated 
as 0, embryonic development is left of 0, postnatal development to the right. The 
approximate time course of cell genesis is indicated by the bar adjacent each cell type. This 
figure is based on the work reported by Young [97]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2.3.  A network of genes essential for Müller glia development.
are based on evidence that Rax
signaling positively regulates expression of hes1, hes5
Hes1 suppresses the proneuronal gene Mash
indicate activation, while red edges indicate repression.  
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 Figure 2.4.  A network of genes essential for ganglion cell development.
are based on evidence that Pax6 actives Math5 expression
Math3 and NeuroD to promote ganglion cell fate
Brn3b and Islet1 expression [251, 272, 273]
Eomes [277], Shh [351] and Barhl2 
between genes indicate activation, while red edges indicate repression.  
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 Figure 2.5. A network of genes essential for bipolar cell development. The edges in this 
graph are based on evidence that Otx2 may affect the competence of progenitor cells to 
adopt a bipolar vs. rod photoreceptor cell fate 
downstream of Otx2 to promote bipolar cell fate
Mash1 and Math3, specify bipolar cell fate
poorly characterized gene relationships.  
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 [254, 285]. Dotted edges indicate indirect or 
 
 
 Figure 2.6. A network of genes essential for amacrine cell development.
graph are based on evidence that 
fate [241, 270], that Pax6 and Six3, with the 
amacrine cell fate [256], and that 
expression [226, 227, 253]. Blue edges 
edges indicate indirect or poorly characteri
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Sox2 activates Pax6 and NeuroD to promote amacrine cell 
cooperation of Math3 and NeuroD, specify 
Foxn4 positively regulates Ptf1a, Math3 and NeuroD 
between genes indicate activation while dot
zed relationships between genes.
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 Figure 2.7. A network of genes essential for horizontal cell development. The edges in this 
graph are based on evidence that Foxn4 positively regulates Math3 and Ptf1a expression
[253], that coexpression of Pax6 and Math3 promotes horizontal cell fate
Ptf1a positively regulates Prox1 expression 
expression [291].  
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[226, 253, 292] which in turn affects Lim1 
 
 
, and that 
 Figure 2.8. A network of genes essential for rod and cone photoreceptor cell development.
The edges in this graph are based on evidence that Otx2 activates Crx 
[303] and BAF [304] repress Crx transactivation. Crx and Nrl synergically activate the rod 
specific pigment rhodopsin [299]
opsins [300, 301]. Nr2e3, which is activated by Nrl represses expression of both S
opsin [312]. NeuroD is necessary for 
opsin and activates M-opsin expression
expression while RXRγ [330] represses S
indicate activation, while red edges indicate repression.  
 
 
 
61 
[305] 
, while Crx promotes expression of M and S cone
sustained expression of TRβ2 [298], which inhibits S
 [327]. RXRα [331] promotes cone-specific gene 
-opsin expression.  Blue edges between genes 
 
 
while Ataxin-7 
-specific 
- and M-
-
 
62 
 
Table 2.1. Pairwise correlation coefficients between genes of the photoreceptor-specific 
seed-network. Pearson correlation coefficients were calculated based on the 
developmental gene expression in rod photoreceptors isolated from retina at ages E16, P2, 
P6 and P10 [332]. Two genes, BAF and 9-cis RA were not present in the expression dataset 
and therefore no correlation coefficient could be calculated (NO DATA).  The seed-network 
is shown in Figure 2.8. 
 
Gene  Gene Correlation 
BAF crx NO DATA 
ataxin7 crx 0.658655867 
crx rhodopsin 0.596816525 
crx s-opsin -0.287648519 
crx m-opsin 0.072625073 
nrl nr2e3 0.995021406 
nrl rhodopsin 0.910738221 
nr2e3 rhodopsin 0.867910201 
nr2e3 s-opsin -0.983763422 
neurod trb2 -0.27275455 
neurod rhodopsin 0.097272022 
rxrg s-opsin 0.940893433 
trb2 s-opsin -0.919529756 
rxra s-opsin -0.59339804 
rxra m-opsin 0.455414641 
9-cis RA rhodopsin NO DATA 
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CHAPTER 3. EnRICH: Extraction and Ranking using Integration and Criteria 
Heuristics 
 
Modified from a paper to be published in 
BMC Systems Biology 
 
Xia Zhang1, 3, M Heather West Greenlee2, 3, 4, §, Jeanne M Serb1, 3 
 
Abstract  
Background 
High throughput screening technologies enable biologists to generate candidate 
genes at a rate that, due to time and cost constraints, cannot be studied by experimental 
approaches in the laboratory. Thus, it has become increasingly important to prioritize 
candidate genes for experiments. To accomplish this, researchers need to apply selection 
requirements based on their knowledge, which necessitates qualitative integration of 
heterogeneous data sources and filtration using multiple criteria. A similar approach can 
also be applied to putative candidate gene relationships. While automation can assist in 
this routine and imperative procedure, flexibility of data sources and criteria must not be 
sacrificed. A tool that can optimize the trade-off between automation and flexibility to 
simultaneously filter and qualitatively integrate data is needed to prioritize candidate 
genes and generate composite networks from heterogeneous data sources.  
Results 
We developed the java application, EnRICH (Extraction and Ranking using 
Integration and Criteria Heuristics), in order to alleviate this need. Here we present a case 
study in which we used EnRICH to integrate and filter multiple candidate gene lists in order 
to identify potential retinal disease genes. As a result of this procedure, a candidate pool of 
several hundred genes was narrowed down to five candidate genes, of which four are 
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confirmed retinal disease genes and one is associated with a retinal disease state. 
Conclusions 
We developed a platform-independent tool that is able to qualitatively integrate 
multiple heterogeneous datasets and use different selection criteria to filter each of them, 
provided the datasets are tables that have distinct identifiers (required) and attributes 
(optional). With the flexibility to specify data sources and filtering criteria, EnRICH 
automatically prioritizes candidate genes or gene relationships for biologists based on their 
specific requirements. Here, we also demonstrate that this tool can be effectively and easily 
used to apply highly specific user-defined criteria and can efficiently identify high quality 
candidate genes from relatively sparse datasets. 
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Background 
Hundreds to thousands of candidate genes, or genes of interest, can now be 
generated from a single experiment utilizing high throughput screening technologies. 
However, the number of candidate genes that can be experimentally studied in-depth is 
often constrained by time and cost. Therefore, prioritization of candidate genes is a critical 
step in the experimental process. Approaches to identify ‘the most promising’ candidates 
are becoming increasingly more sophisticated. For example, when microarray studies were 
initially reported, ‘the most promising’ candidates were often the most differentially 
expressed and could be obtained by a simple ranking of candidates based on fold change.  
As more data has become available, biologists have begun to look for ways [122, 352-354] 
to use multiple data sources to increase the accuracy of candidate gene prioritization. Some 
tools have already been developed to address this need [127-131, 136, 355].  These tools 
prioritize candidates by their similarity to genes already known to be important for a 
particular biological process (e.g., genes known to regulate cell cycle in yeast). Multiple 
data sources including published literature, gene sequence, functional annotation, etc. can 
be considered when comparing the similarity of candidates to ‘known genes’.  These tools 
[127-131, 136, 355] have made important progress towards the problem of candidate 
prioritization. However, these tools use data queried from predetermined sources, such as 
public databases, and include embedded criteria. Thus, these software packages have 
limited utility.  
Biologists, with expertise in a given area, generally already have a list of criteria that 
could be applied to identify high quality candidates. Likely, for a given set of experiments 
and resulting datasets, the best candidates may satisfy one set of criteria in one dataset and 
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a separate set of criteria in another dataset. Currently, there is no tool that allows 
simultaneous consideration of heterogeneous datasets to identify candidates that satisfy 
multiple criteria. This problem does not only relate to candidate genes, but also to putative 
relationships between genes in networks. 
Putative gene relationships can be inferred from many heterogeneous sources (e.g., 
physical interactions, genetic interactions, expression correlation and interactions 
predicted by computational models). While each of these relationships from a given dataset 
should be interpreted differently (and subject to very different criteria), the ability to easily 
hypothesize gene relationships based on their meeting appropriate criteria in multiple 
datasets is an attractive prospect. This task not only calls for an automated filtering and 
integration tool, but also demands great flexibility of data sources and the ability to set 
filtering criteria. Finally, for proper interpretation, visualization of the resulting network 
must facilitate inspection by 1) retaining the original data sources of each putative 
relationship and 2) providing a mechanism to easily manage the size of the displayed 
network. While some tools have been developed to generate composite networks from 
multiple data sources (e.g., the Cytoscape [356] plugin CABIN [162], GraphWeb [163] and 
GeneMania [164]), they do not fully address the problems stated above.  For example, 
CABIN supports only one filter for a single source network and thus multiple criteria 
cannot be applied. GraphWeb [163] does not support filtering by user-defined criteria and 
interactive network visualization. GeneMania [164] helps to predict the function of a set of 
input genes by utilizing functional association data to generate a functional relevant 
network, but does not address integration of user-determined data and filtration with user-
defined criteria. 
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We identified the need for a tool that is able to: 1) filter individual datasets using 
appropriate criteria and then integrate them to prioritize candidates that meet the criteria 
in multiple datasets; 2) allow users to define the most appropriate datasets and filtering 
criteria; and 3) provide an interactive visualization to facilitate the generation of an 
integrated network with a manageable size and connectedness. To address the open 
demand of filtering and qualitative integration of heterogeneous datasets, we have 
developed a stand-alone, portable and flexible java application with its own user-
interactive visualization. EnRICH (Extraction and Ranking using Integration and Criteria 
Heuristics) will assist biologists in prioritization of genes and gene relationships from 
heterogeneous-source data. 
 
Implementation  
EnRICH was implemented in Java (SE 6 JDK). EnRICH visualization was written in 
Processing (http://processing.org/), an open-source programming language to create 
images, animation and interactions.  The separation of non-visual and visual modules of 
EnRICH lays a flexible foundation for future development and provides the user easy access 
to both the text and visual output results. 
 
Design 
The objectives of EnRICH are firstly to provide a tool for integration of multiple or 
heterogeneous data sets to prioritize candidate molecules that fulfill user-defined criteria, 
and secondly to make the integration process flexible and simple for biologists who have 
little programming skill. Our aim-oriented design principles are 1) user-defined data 
sources and criteria, 2) simplicity which allows straight-forward application of user-
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defined criteria to filter user-defined datasets, and 3) platform independence.  
The overall architecture of EnRICH is reflected in its workflow-like graphical user 
interface (GUI) (Figure 3.1).  The first component (numbered as step 1 in the GUI) accepts a 
single file or a directory of files as input data and lists all files that can be selected for 
analysis. The second component (numbered as step 2 in the GUI) allows the user to display 
the selected file as a table and edit the table. The third component (numbered as step 3 in 
the GUI) enables the user to specify filtering criteria for each attribute of the selected file.  
The fourth component (numbered as step 4 in the GUI) displays all uploaded files for the 
user to customize an integration pool. It also provides the user running options on whether 
to apply filters that are already specified in step 3.  The fifth component is a dialog window, 
which appears when the integration run is finished, and gives the user the option to save or 
visualize the result. For network data, EnRICH has an additional visualization component 
where the user can do an interactive visual analysis of the integrated network.  
 
Input data 
The current version of EnRICH accepts two types of data: list and network. A list is a 
set of elements that could be genes, proteins, etc., which have their own unique 
identification code or name. List data can come from a large variety of sources. For 
example, a list of genes can be differentially expressed genes (DEGs) from the analysis of a 
microarray experiment, genes identified by genome-wide association mapping, or genes 
retrieved from a database query. Each list member may have one or more attributes.  For 
example, each gene in a list of DEGs has its own significance value, functional annotation, 
etc. For EnRICH, list data is represented as a named matrix that is composed of one column 
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of elements and zero to multiple attribute columns. Attributes can either be value 
attributes that will be taken as mathematical values or label attributes treated as tags.  
A network is a set of nodes that are interconnected by edges representing particular 
relationships between nodes. Like list data, network data can originate from heterogeneous 
sources including yeast two-hybrid experiments, computational or statistical inferences, 
literature summaries or database queries. Although there are several standard languages 
or formats for network representation, we assume that biologists may not be familiar with 
those standards.  Thus, EnRICH applies a popular node-pair/edge list format as the input 
format for network data, where an edge is denoted by the pair of nodes it connects.  In the 
matrix format, network edges are represented by two columns of node names. Like list 
data, network edges may have values and label attributes. Accordingly, a network is a 
named matrix consisting of two columns of nodes and zero to multiple attribute columns. 
EnRICH allows blank fields in the attribute column when data are missing. 
 
Running mode 
EnRICH runs in two modes: undefined (without filters) and defined (using specific 
criteria to filter attributes). The undefined mode simply ignores the attributes of networks 
or lists. Each list or network is considered as a source, and all sources will be merged 
together. The defined mode simultaneously considers integration of networks or lists as 
well as user-defined criteria (which filters out elements that do not meet the criteria) over 
each network or list. For both types of running modes, candidates (edges of a network or 
elements of a list) are ranked by their reoccurrence across all sources after integration. The 
filtering process is completely user-defined. Because the filter is totally attribute-based, the 
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user sets filters most appropriate for their biological question, which may include a 
combination of filters for each attribute, and even multiple filters for multiple attributes. 
For example, two of the comparison operators (<, <=, >, >=, ==) applied at the same time 
can be used to set a cutoff range for value attributes or several tags can be used (with an OR 
operator between them) when the user wants to select multiple label values (e.g. two 
annotations) for one attribute. When there are multiple attributes, multiple filters (with an 
AND operator between them) can be applied simultaneously. 
 
Text Output 
EnRICH saves output results as a tab-delimited text file. In the output text file, the 
user can see what files were integrated, which filters were applied to each file, and the 
result. For list data, the result is a table, which consists of three columns: the label of an 
element, its reoccurrence across all lists, and names of source-lists. For network data, the 
result includes four tables: node statistics, edge statistics, nodes, and edges. The node 
degree reveals topological importance of the node, so the table of node statistics contains 
two columns, one column is the node degree (the number of connections a single node has) 
and the other is the number of nodes that are greater than or equal to (>=) this node 
degree. For the table of edge statistics, one column is edge reoccurrence (the number of 
times a single edge is recovered across all datasets) and the other is the number of edges 
that have an edge reoccurrence that are greater than or equal to (>=) this edge 
reoccurrence. The table of nodes and the table of edges are quite similar. Each has a column 
of nodes/edges, their reoccurrence, and source-networks. The only difference between the 
node and edge tables is that a node is represented by the node label and an edge is denoted 
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as two node labels. The table of edges is a tab-delimited data table composed of several 
columns such as node label name, edge reoccurrence and source. Therefore, if desired, the 
user can directly copy or import them into another network visualization tool such as 
Cytoscape [166, 356]. 
 
Visualization 
EnRICH enables an interactive visual analysis of the integrated network without 
depending on a third-party visualization software. EnRICH network visualization consists 
of two components for user interaction: the integrated network and the plot of network 
statistics (Figure 3.2). In the integrated network, an undirected edge is drawn as a blue line 
while a directed edge is drawn as a pink line with a pink arrow to indicate the direction of 
the interaction (e.g. transcriptional regulation). A blue line with a pink arrow is used to 
denote merged undirected and directed edges. All edges and nodes can be repositioned, 
without changing connections, by clicking and then dragging the item on the screen. In 
addition, the user can click to show or dissipate node labels and edge sources at the node- 
and edge-specific level, instead of the whole network level. The plot component has two 
plots: 1) the number of nodes vs. node degree plot and 2) the number of edges vs. edge-
reoccurrence plot. The number of nodes and the number of edges are two aspects of the 
network size, while the node degree reveals topological importance of node.  Edge 
reoccurrence is the number of times the edge is recovered in different data sources, which 
implies the reliability of an edge. In conjunction, the two plots are used to balance the 
visualization of network size and quality. All data points in the two plots are clickable to re-
draw the integrated network at the selected level of node degree or edge reoccurrence. 
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This interactive plot gives the user an easily visible comparison of node degree, edge 
reoccurrence and network size, and allows the user to simultaneously visualize the 
network at corresponding levels. EnRICH also allows the exportation of the network as an 
image file in TIFF format, which is widely supported. 
 
Result and Discussion 
Application of EnRICH 
Retinal disease genes are genes that, when knocked out or mutated, cause retinal 
degeneration (https://sph.uth.tmc.edu/retnet/disease.htm). The identification of retinal 
disease genes is a major goal of retinal degenerative disease research, and as part of the 
effort, there have been a significant number of experiments that describe transcriptional 
changes during normal retinal development [280, 332, 343, 344, 357-359]. Here, we 
present a case study in which we use EnRICH to integrate multiple gene lists to identify 
potential retinal disease genes.  
Nrl [309, 311, 312, 360] is a retinal disease gene that is associated with the retinal 
degenerative disease enhanced s-cone syndrome [316].  When Nrl is mutated, the resulting 
phenotype is an abundance of s-cone photoreceptors at the expense of rod photoreceptor 
differentiation [310, 311], leading to the eventual death of all photoreceptors.  During 
normal development, Nrl influences the cone versus the rod cell fate decision by activating 
rod-specific genes, including the genes Rho and Nr2e3 [361].  Rho [362-364] is a rod-
specific gene, the mutation of which leads to rod photoreceptor cell death and retinal 
degeneration. Nr2e3 [318, 319] is also essential during retinal development, as it promotes 
the expression of rod-specific genes (including Rho) and represses the expression of cone-
specific genes in rods. The mutation of Nr2e3 also causes enhanced s-cone syndrome [314].  
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Based on the known regulatory relationships between these three disease genes and their 
importance for normal photoreceptor development, we rationalize that the behavior of 
these genes would make good criteria to identify additional retinal disease genes. 
Using these assumptions, we defined the following criteria to identify retinal disease 
genes: 1) candidates must be highly co-expressed with Nrl, Nr2e3 and Rho during rod 
photoreceptor development of wild-type mice; and 2) candidates must be disregulated 
when Nrl is knocked out (as Nr2e3 and Rho are). With these criteria in mind, we decided to 
use a microarray dataset [332] (GSE4051), which profiles gene expression in isolated rod 
photoreceptors at multiple developmental stages (E16, P2, P6, P10, 4-weeks) in both Nrl-
knockout and wild-type mice. In these microarrays, we confirmed that Nr2e3 and Rho are 
highly co-expressed with Nrl in wildtype while in Nrl-mutant no statistical evidence 
supports that they are still co-expressed. 
According to the corresponding workflow (Figure 3.3), we prepared, and 
subsequently integrated, three types of gene lists which are: Type 1) Genes that are co-
expressed with Nrl, Nr2e3 and Rho in developing wild type rod photoreceptors; Type 2) 
Genes that are co-expressed with Nrl, Nr2e3 and Rho in developing photoreceptors isolated 
from Nrl-mutant retinas; and Type 3) Differentially expressed genes (DEGs) at each age 
when comparing gene expression in wild-type rod photoreceptors to Nrl-knockout rods.  
Each list contained attributes that were used to apply criteria filters (i.e. pairwise 
correlations for type 1 and 2, age at which expression was up or down regulated for type 
3).  To carry out the workflow, we first specified filtering criteria for each list. This is a key 
element of EnRICH, where users can simultaneously query multiple datasets to generate an 
‘integrated result’.  For this experiment, eight list datasets were integrated. The filtering 
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criterion for six of the lists was an absolute value of the correlation coefficient greater than 
0.9, while the filtering criterion for the two differentially expressed gene lists was the 
developmental time points P6 and P10 (for criteria on each single list, see Appendix B. 
Additional file 1).    Candidates that satisfied these filtering criteria in eight lists were 
identified as the highest priority candidates.  All the lists were prepared from standard 
analyses of the dataset GSE 4051 (calculation of co-expression coefficients within a 
genotype and differentially expressed genes between genotypes).  
The execution of our workflow generated five candidate genes (see Appendix B. 
Additional file 2) from an initial pool of 272 unique differentially expressed genes (see 
Appendix B. Additional file 3). Based on a literature/database search, four of our five 
candidate genes (pde6b, gnb1, guca1a and cgna1) are confirmed retinal disease genes [365-
374], and the fifth gene (kcne2) has been shown to be up regulated during a 
neuroinflamatory response in the retinas of diabetic rats [375], making it a reasonable 
candidate for a disease gene as well. Thus, in our example analysis to identify disease 
genes, 80% of our candidates are known disease genes, while the remaining candidate has 
a demonstrated tie to the diseased retina, and is perhaps a high quality candidate.  Using a 
Fisher test we also concluded that retinal disease genes are significantly overrepresented 
in the genes prioritized by EnRICH, compared with genes not prioritized by EnRICH (see 
Appendix B. Additional file 3). Our case study demonstrates that a well-conceived data 
integration and criteria-based filtration, as implemented in EnRICH, can effectively identify 
a limited number of high quality candidate genes for careful hypothesis-based 
investigation. Conversely, if the number of candidates returned is too small, slight 
adjustments in the filtration criteria may be easily made to generate a larger, while still 
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reasonably-sized, candidate pool. 
 
Conclusions 
EnRICH is a free java application which can qualitatively integrate results from 
large, heterogeneous data sources while simultaneously applying filters to each of them. It 
allows the user to define data sources, and to integrate them as well as specify multiple 
sorting criteria specific to each data source. It provides interactive network visualization 
tool for the user to identify an integrated network with a desirable balance between 
network size and quality. With EnRICH, biologists have an automated yet flexible 
integration tool to carry out their data analysis and effectively prioritize candidate genes 
for further investigation.  
 
Availability and requirements 
Project name: EnRICH 
Project home page: http://xiazhang.public.iastate.edu/ 
Operating system(s): platform-independent 
Programming language: Java 
Other requirements: Java 1.4.2 or higher 
License:  GNU General Public License 
Any restrictions to use by non-academics: NO 
 
Additional files 
Additional file 1: Gene lists and their filtration criteria prior to integration. This file 
includes a supplementary table that displays names and descriptions of gene lists for 
integration in case study and some further explanation on the sources of gene lists. 
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Additional file 2: Gene candidates resulting from the EnRICH filtration and 
prioritization analyses. This file is the supplementary table of the five gene candidates from 
the prioritization by using EnRICH in case study.  
Additional file 3: Description of data processing. This file includes detail description 
of data pre-processing for case study, and analysis of the significance of case study result. 
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manuscript. XZ coded this software and conducted case study presented in this manuscript. 
All authors read and approved the final manuscript. 
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Figure 3.1. EnRICH graphical user interface. There are four major components in the user 
interface, which are numbered as 1, 2, 3 and 4. Component 1: upload input data; 
Component 2: browse or edit the selected file; Component 3: specify filtering criteria of the 
selected file; Component 4: select files to define integration pool.  
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Figure 3.2. EnRICH visualization window. Left: integrated network from synthesizing data. 
Circles represent nodes, while circle size represents node degree (the number of 
connections one node has). Lines represent edges of a network and line stroke represents 
the amount of edge reoccurrence (the number of times one edge is recovered across data 
sources). Undirected edges are represented by blue lines, while directed edges are pink 
lines with pink arrows. The merged edge of undirected and directed data is denoted by 
blue line with a pink arrow. Right: top panel is the statistical plot of node degree vs. the 
number of nodes. Bottom panel is the statistical plot of edge reoccurrence vs. the number 
of edges.  In the software, all data points in the two plots are clickable to update 
visualization of the integrated network. 
 
 
 
 
 
 
 
 Figure 3.3. Case study workflow.  A. Rationale illustrates our current knowledge of Nrl, 
Nr2e3 and Rho and their behaviors in the dataset we analyzed. B. Workflow displays the 
steps that we must go through in order to apply our criteria to identify candidate genes. 
These steps are executed by iRank to obtain candidate genes. B. Workflow is the 
implementation of the investigation process based on the rationale (A).
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Abstract  
In the recent past, genomic or transcriptomic studies were limited to a small number of 
model organisms that had complete genome sequences available.  Rapidly-advancing next 
generation sequencing technologies have created numerous opportunities to investigate 
previously understudied organisms. And applications of these technologies have been 
generating new datasets in an exponential way.  To quickly annotate new datasets becomes 
a bottleneck of data analysis, hurdling further investigations to some extent. This exposes 
the need to identify putative orthologs between model and non-model organisms in a fast 
and genome-wide fashion. We propose a fast, across-genome matching method that 
alleviates the need for screening all homologous gene relationships between two genomes 
for one –to –one gene matches as putative orthologs. Our results demonstrated this method 
performed better or as good as other putative orthologs-identifying methods. Our results 
also showed the relationship between the global homology and the number of putative 
orthologs between two genomes fits a nonlinear growth model. Furthermore, parameters 
of this nonlinear growth model are tightly related to evolutionary relationships. Our results 
suggest exploiting this relationship may also be a prosperous approach to predict 
evolutionary relationships between known and unknown organisms. Using the tool 
package (AGEM) that was created to implement the method we proposed, investigators 
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would be able to easily generate a gene dictionary to translate between any two genomes 
for further analysis. 
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Introduction 
Recent technological advances in high-throughput sequencing have allowed for the 
genomic or transcriptomic profiling of nearly any organism [22, 25, 376, 377].  This 
technological advance is particularly important for the development of a more 
comprehensive [holistic] view of biological systems which was previously limited to model 
organisms but is expanding to include non-traditional models [378, 379]. However, the 
next challenge/bottleneck for research on these lesser known organisms lies in gene 
annotation. One approach to this problem is to identify similar or homologous DNA regions 
between traditional models where gene function has been experimentally demonstrated, 
with similar, putatively homologous, DNA regions in non-model organisms [56, 380].  This 
task in not trivial, because each query sequence of a non-traditional model requires 1) the 
unknown sequence (query) to be aligned against a target genome or database of traditional 
models and 2) appropriate filtering of alignment results (hits). Once putative homologs 
have been identified for the unknown sequence, the homolog match can then be leveraged 
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to infer gene function.  In this approach, it is extremely important to effectively exploit 
everything that is known about the identified homologs.  In addition to GO terms [58, 59], 
gene interactions between the identified homologs are one important informational source 
to infer function. However, the application of interactions requires projections between 
two genomes that are based on interacting genes, instead of a set of individual genes. In 
other words, across-genome gene/protein correspondence that is not one-to-one can 
dramatically affect the network topology, resulting in noise that may eclipse homologous 
relationships. Thus, it would be very helpful to effectively obtain cross-organismal 
matching in which each query protein/gene sequence of one genome has its own unique 
homologous counterpart in another genome. In addition, this matching must be genome-
wide to avoid creating a ‘moving target’ where the one-to-one correspondence changes 
with the subset of genes. While non-model systems must utilize sequence homology for 
gene annotation, model organisms also heavily rely on sequence homology to compare and 
integrate data cross species to infer evolutionary relationships[183] , characterize 
biological functions [381], and evaluate transferability of research results in clinical trials 
[382, 383], etc. In situation such as comparison of networks between two organisms[384], 
matching across genomes to get a one-to-one gene/protein match is highly desired. In all, 
this post-genomic era exposes the need of model and non-model organism to creatively tap 
sequence homology to plug into the tree of life.  
When it comes to utilizing sequence homology for genome/gene comparisons, there 
are at least three essential steps. The first step is to align query sequences against an 
appropriate set of target sequences. Thus, it is necessary that an aligning algorithm or tool 
is selected based on the research objective. For example, investigating phylogenetic 
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relationships requires a sequence alignment of multiple homologs across different 
organisms, while a (reciprocal) blast against closely related genomes is more appropriate 
when trying to identify functionally similar sequences. The second step is to prune the 
sequence alignment results, in order to reduce the amount of noise introduced into 
subsequent analyses. For example, blasting a sequence against a genome to identify 
putative homologs probably will return a set of hits that will include false positives even if 
the e-value cut-off is extremely low. This could arise when the query and subject share a 
high sequence identity over a very short sequence length.  The third step is to apply the 
pruned alignment hits to downstream analyses, which in our case is requires obtaining a 
one–to-one gene/protein match. 
Assuming the aforementioned first and second steps are carefully implemented, 
modeling the genome matching as maximum bipartite matching (See Box 1.)[385] provides 
a good solution. Maximum bipartite matching reduces the complicated relationships 
between two parties to a matching that only contains one-to-one correspondence, while 
maximizing some sort of measure associated with the matching.  Actually, one of the typical 
maximum bipartite matching algorithms, the maximum weighted bipartite matching, was 
successfully applied to problems such as the identification of putative orthologs [386] and 
the evaluation of genome architecture [387].  Here we propose the maximum weighted 
bipartite matching at fixed cardinality as a new way to approach genome matching.  This 
algorithm matches putatively homologous gene sequences between two genomes by 
simultaneously maximizing their sequence homology (maximum weighted) (See Box 1.) 
and maximizing the number of matched genes (maximum cardinality) (See Box 1.). 
84 
 
Moreover, it provides an insight on how the evolutionary relationship between genomes 
affects the matching dynamics. 
In order to test this proposed method, we executed this algorithm on four genome 
comparisons: mouse vs rat; mouse vs human; mouse vs chicken; and mouse vs zebrafish. 
Our results demonstrate that our method performed better or at least as good as relevant 
work in matching homologous genes/proteins. Further, our results demonstrated the 
relationship between the genome-wide homology and the number of matched homologous 
genes/proteins. From the results, we also found an interesting feature that may be used to 
predict evolutionary relationships of genomes. 
During the implementation of our studies, we created a python tool called AGEM. It 
is freely available online at https://github.com/versaille/AGEM and provides an 
alternative for investigators whose analyses require or would benefit from one to one 
genome-wide gene matching between organisms.   
 
Results 
Maximum weighted bipartite matching at fixed cardinality 
Bipartite matching models the elements of the two entities that need to be matched as 
a bipartite graph and then searches a matching on this bipartite graph (See Box 1.).   We 
modeled the relationship between two different classes of objects (e.g., genomes) at the 
resolution of gene/protein as a bipartite graph (See Box 1.). Under this model, 
genes/proteins of two genomes would be the vertices V of a bipartite graph G, and would 
be in either X or Y partitions of V depending on which genome they belong to. Putative 
homologous relationships of genes/proteins between the two genomes would be 
represented by the edges E between vertices in X and vertices in Y, and quantitative scores 
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that measure the homology extent would be the weights W associated with these edges.  
We then applied the algorithm of maximum weighted bipartite matching at fixed-
cardinality to this model (For more details on this method, see Technical Supplement). This 
algorithm searches the maximum weighted bipartite matching (See Box 1.) for any 
potential cardinality (see Box 1) from minimum to maximum. That is, for a specific number 
of matched elements (or a specific cardinality), there could be multiple matchings (See Box 
1.) and only the matching (see Box 1.) that maximizes the sum of weights of edges is 
chosen. Maximum cardinality bipartite matching (referred as ‘maximum cardinality’ below, 
see Box 1.) and maximum weighted bipartite matching (referred as ‘maximum weighted’ 
below, see Box 1.) are the two major types of bipartite matching. Both are produced during 
the execution of this algorithm. Maximum cardinality bipartite matching maximizes the 
number of homologous gene/protein pairs between two genomes. Maximum weighted 
bipartite matching maximizes the global sequence homology measure between 
homologous gene/protein pairs.  
To estimate the performance of this algorithm, we used the number of matched 
homologous gene pairs between two genomes as an indicator. Our results are as good as or 
better than that of relevant work, as shown in Table 4.1. We implemented this algorithm on 
data from four organismal comparisons: mouse to rat, mouse to human, mouse to chicken, 
and mouse to zebrafish. We compared the results to relevant work that are shown as ‘EGM’ 
(Encapsulated gene by gene match) [386] and ‘HomoloGene’ [388]. ‘EGM’ is an ortholog-
identifying method that employs maximum weighted bipartite matching to match across 
the same gene family among different organisms.  ‘HomoloGene’ is a NBCI database that 
detects and stores the orthologous and paralogous gene groups for several eukaryotic 
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model organisms. We used the number of homologs identified by ‘EGM’ and ‘HomologGene’ 
as a benchmark to which we compared the performance of our algorithm. For ‘mouse-rat’ 
and ‘mouse-human’ comparisons, both ‘maximum cardinality’ and ‘maximum weighted’ 
beat ‘EGM’ and ‘HomoloGene’. For the ‘mouse-zebrafish’ comparison, ‘EGM’ generates a 
larger number than ‘maximum cardinality’ and ‘maximum weighted’. We attributed this to 
a less stringent filtering criterion on alignment hits used by ‘EGM’.  As we reduced the 
strictness our filtering criteria (still more strict than what is applied by ‘EGM’), the number 
of matched homologs increases from 10729 to 12310 for ‘maximum cardinality’ and from 
10705 to 12282 for ‘maximum weighted’ (See Table 4.1, ‘reciprocal & stringent’ and 
‘reciprocal & less stringent’ columns). For both ‘mouse-chicken’ and ‘mouse-zebrafish’, 
‘HomoloGene’ seems to win over all other methods listed in Table 4.1. However, 
‘HomoloGene’ builds homologous gene groups for multiple organisms. That is, the number 
given by ‘HomoloGene’ is the number of genes that can be matched to all other eukaryotic 
groups that it stores instead of only mouse, meaning some genes out of the 13,149 for 
chicken and of 14,183 for zebrafish might not even be matched to mouse.  
Our results also show how pre-processing steps influence the performance of the 
algorithm.  For all four organismal contrasts, the results of maximum cardinality and of 
maximum weighted bipartite matching are further categorized by different pre-processing 
strategies into three sub-columns that are labeled as ‘unilateral & stringent’, ‘reciprocal & 
stringent’ and ‘reciprocal  & less stringent’. ‘Stringent’ and ‘less stringent’ indicate the 
filtering criteria of sequence alignment results, or the cut-off levels (see Table 4.1 legend 
for more details) that define the homologous genes (see Method/Sequence alignment and 
homologs).  ‘Reciprocal’ and ‘unilateral’ denote how identified homologous relationships 
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were parsed for the implementation of this algorithm (see Table 4.1 legend for more 
details).  For each organismal contrast, there is quite a difference between ‘stringent’ and 
‘less stringent’, meaning the criteria that define the homologous genes have a significant 
impact on the final result. This is understandable, since the less stringent the criteria are, 
the result will include more putatively homologous relationships between two genomes. 
The reason that ‘reciprocal’ and ‘unilateral’ does not differ much are very likely due to our 
stringent filtering criteria of sequence alignment results, since with strict filtering criteria, 
homologous genes are more prone to be reciprocal instead of unilateral.  
   
Cardinality vs. Global weight  
To display the dynamics between the number of matched genes/proteins and the 
global sequence homology between two genomes, we graphed cardinality against 
maximum global weight for every matching generated by the execution of algorithm as 
previously described. As shown in Figure 4.1A, there is a correlated relationship between 
cardinality and global weight which fits a nonlinear growth model. That is, as cardinality 
increases, global weight increases too, but not at a linear rate. Instead, global weight 
increases at a decreasing rate. This means the global sequence homology goes up at a 
declining rate as the number of matched homologous genes/proteins rises. As either of 
them reaches its own maximum, cardinality and global weight converge with each other. 
The trade-off between maximum cardinality and maximum global weight only happens 
within a tiny range near to maximum global weight (Figure 4.1B). Results from other 
organismal contrasts like mouse vs. rat, mouse vs. chicken and mouse vs. zebrafish show 
similar patterns. This demonstrates that the maximum number of matched homologous 
genes/proteins to some extent means the maximum global sequence homology. 
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Knowing how cardinality and global weight relate to each other is important to 
increase efficiency of matching. The algorithm we described and executed here can 
simultaneously generate cardinality and global weight. However, provided the relationship 
of cardinality and global weight prevails, it would more efficient to choose to compute 
either maximum cardinality bipartite matching or maximum weighted bipartite matching 
based on the specific need or objective of the project, because the two types of matching 
require very different computational intensities. The Hopcraft-Karp algorithm for 
maximum cardinality bipartite matching has a running time of O (||√||) (here|| is the 
number of edges and || is number of vertices). And the Hungarian algorithm for maximum 
weighted needs a running time of O(||  || 	 ||||). This means it would be much 
faster to compute maximum cardinality bipartite matching than maximum weighted 
bipartite matching as the number of vertices || increases. Since global weight and 
cardinality converge with each other as either of them reaches maximum, maximum 
cardinality, instead of maximum weighted bipartite matching would be an appropriate 
selection to compute. This would dramatically speed the computation time, especially 
when the number of genes included in the dataset is very large. 
 
Genome matching and evolutionary relationship 
From figure 4.2A, we can see for all organismal contrasts, the general relationship 
between cardinality and global weight resembles a nonlinear growth pattern. What differs 
among organism contrasts are the height, length and curviness. Comparing these 
differences in the context of their evolutionary relationships (Fig. 2B), we found that when 
two organisms more recently shared a common ancestor, the higher the curve of the 
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contrast between them is, and the faster the global weight increases as cardinality 
increases.  Considering the height of the curve represents the global weight between two 
organisms, it means the global weight may indicate the global homology between two 
organisms. This does not only happen to the absolute height of the curve, but the height of 
each point on the curve. That is, for each cardinality value (or value on x axis), the global 
weight (corresponding value on y axis) is higher for more closely related organisms. 
Translating cardinality into the number of matched homologous gene pairs, this also means 
that, as the number of homologous gene pairs being matched increases, the global 
homology increases faster for evolutionarily similar organisms. We regarded the curve as a 
nonlinear growth model and quantitatively describe it by function below:  

     
In this function, Y represents global weight and X represents cardinality. The 
function parameter b implies the speed of growth, c describes the full growing size and a 
determines the starting size.  In figure 4.2A, a equals to 0 for all four curves while b and c 
are bigger for evolutionarily closer organisms. This model suggests its parameters are able 
to indicate evolutionary relationships or vice versa.  
Discussion 
We modeled the matching between any two genomes in a one-to-one fashion as a 
bipartite matching problem and then proposed maximum weighted bipartite matching at 
fixed cardinality as a solution to approach this problem.  We also demonstrated how the 
pre-processing steps such as aligning sequences and pruning sequence alignment results 
influence the performance of our method. Additionally, we built a python tool AGEM that 
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can implement the matching algorithm for other investigators to match datasets across 
genomes that are not included in this study. 
The relationship between global weight and cardinality fits a nonlinear growth 
model. What’s more, the closer two organisms are evolutionarily, the bigger the 
parameters (b and c) of this nonlinear growth model is. Thus, the parameters for a given 
matching here can indicate similarity between organisms and may be a good predictor of 
evolutionary relationships.  This feature has the prospect of being applied to predict 
evolutionary relationships for known and unknown genomes. Such prediction is based on 
the global effect of the whole genome, instead of only single gene or a couple of genes. 
Traditionally, to delineate evolutionary relationships between organisms, evolutionary 
biologists first do multiple sequence alignments on protein sequences of the same 
conserved gene among different organisms and then construct a phylogenetic tree based 
on the alignment result. This process inherently limits the data being used from one gene to 
at most a few genes, limiting perspective. Increasing the data being used from a couple of 
genes to the whole genome may produce more accurate estimate of evolutionary 
relationships. However, two important questions highlight the need for further 
comparisons using more genomes. First, does the aforementioned feature (model 
parameter vs. evolutionary relationship) hold true for other genomes? Second, even it 
holds true, what is the resolution between   closely related organisms? That is, using this 
feature we can easily resolve mouse to human from mouse to rat, but can human to 
chimpanzee from human to rhesus monkey be resolved as easily? Answers to the two 
questions will help determine at what relatedness this approach is appropriate. 
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Our method provides a fast solution to identify putative orthologs at the genome-wide 
scale. However, like EGM, this tool is not appropriate for the definitive identification of 
orthologs. To label ortholog/paralog in a strict evolutionary sense, a phylogenetic tree that 
includes out-group should be constructed, this process is effective at the gene-level but not 
yet the genome-level. So instead of labeling ortholog/paralog, we used stringent cutoff on 
alignment length and percent identity to remove artifacts and control the homogeneity of 
homologs being matched.  Our method quickly screens homologous relationships between 
two genomes and generates a genome-wide batch of putative orthologs, providing a search 
base for more in-depth study.  
The utility of our approach can be illustrated in two different examples.  First, by 
generating a genome-wide batch of putative orthologs, evolutionary biologists can gain a 
global outlook to better target a subset of genes for further analysis and then apply 
traditional method of constructing phylogenetic tree.  Second, comparison of networks 
between organisms requires genome-wide one-to-one gene matching. 
 The method we proposed here, together with the tool we created to help implement the 
method, will help to address the needs of those working on genomes that are not currently 
within the public database.   
 
Methods 
Sequence alignment and homologs 
Protein sequences of mouse (Mus musculus), rat (Rattus norvegicus), human (Homo 
sapiens), chicken (Gallus gallus) and zebrafish (Danio rerio) were downloaded from the 
National Center for Biotechnology Information (NCBI) genome database 
(ftp://ftp.ncbi.nih.gov/genomes/ ). We used the NCBI standalone BLAST (ncbi-blast-
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2.2.27+) to run the sequence alignment 
(ftp://ftp.ncbi.nlm.nih.gov/blast/executables/LATEST/). We made five blast databases, 
one for the protein sequences of each organism.  Then we did a reciprocal blastp between 
mouse and mouse, mouse and rat, mouse and human, mouse and chicken, and mouse and 
zebrafish to identify putative homologous hits. We set the cut-off e-value (=expectation 
value) at 1e-30 which is particularly strict. To further prune the alignment hits, we filtered 
them by alignment length, percentage of identical matches, and bit score 
[http://www.ncbi.nlm.nih.gov/books/NBK21097/] and used as a homology score below. 
Two levels of filtering criteria were used to define the homologous relationship. For 
‘stringent’, only hits that have an alignment length of 200 amino acids (aa) or greater, a 
percentage of identical matches of 50 or greater than that, and a bit score that equals to or 
greater than 200 aa were regarded as homologs and kept for further analyses. For ‘less 
stringent’, the cutoffs are alignment length being 120 aa, percent identity being 50 and bit 
score being 150.  
 
Analysis pipe  
Each pair of homologs has a homology score (=bit score) after alignment.  We used 
this homology score as the weight of an edge between a pair of homologs in two ways. For 
‘reciprocal’ way, only those pairs of homologs that have each other in their hits are kept 
and the weight is the average of their reciprocal homology score (computed by the script 
combine_reciprocal.py in our python tool AGEM). For ‘unilateral’ way, any pair of homologs 
that is either reciprocal or unilateral is kept. If being reciprocal, the weight is the average of 
their reciprocal homology score. If being ‘unilateral’, the weight is the half of the only 
homolog score (computed by the script combine.py in our python tool AGEM). After that, 
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we searched the maximum cardinality or the potentially maximized number of matched 
homologs between the aforementioned four organism contrasts (computed by the script 
hopcraft_karp.py in our python tool AGEM).  Also we searched maximum weighted 
bipartite matching at fixed cardinality that includes from minimum to maximum 
(computed by the script weighted_diagnostics.py in our python tool AGEM) 
 
Software availability 
The free python tool we created can be found and downloaded at the open source 
site http://www.github.com/versaille/AGEM. 
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XZ, JMS and MHWG conceived the idea and drafted the manuscript. XZ proposed the 
specific method, coded the python package AGEM and conducted data analysis.  
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Figure 4.1. Matching between mouse and human. Both A and B are based on the matching 
between mouse and human with the preprocessing strategies being ‘unilateral & stringent’. 
A plots cardinality against global weight of the maximum weighted bipartite matching at 
this specific cardinality. B shows some of the specific data points of the plot A, especially 
the data points that are around the maximum of cardinality and of global weight. Entries in 
B shaded in grey are the maximum of cardinality 18628 and the maximum of global weight 
19482865.  
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Figure 4.2. The matchings of four organism contrasts and their evolutionary relationships. 
A is a plot that displays the relationship between cardinality and global weight of the 
maximum weighted bipartite matching at this specific cardinality of four organism 
contrasts which are mouse and rat (black), mouse and human (blue), mouse and chicken 
(green) and mouse and zebrafish (red). What were used to plot A are results with the 
preprocessing strategies being ‘reciporcal & stringent’. B indicates the evolutionary 
relationships between mouse and the other four organisms that include rat, human, 
chicken and zebrafish in colors correspond to plot A.  
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Table 4.1. The identifications of putative orthologs of four methods. This table lists the 
number of matched homologs that came from four methods/sources for four organism 
contrasts. The four methods include two typical bipartite matching methods that are 
maximum cardinality and maximum weighted, one published method referred as EGM that 
employed maximum bipartite matching in one of its steps, and the NCBI database 
HomoloGene that stores homologs of several well established eukaryotic genomes. The 
four contrasts are between organisms that are increasingly evolutionarily divergent from 
each other. They are mouse and rat, mouse and human, mouse and chicken, and mouse and 
zebrafish. ‘Stringent’ and ‘less stringent’ indicate different filtering criteria on sequence 
alignment results (blastp hits), and ‘uni’ (unilateral) and ‘re’ (reciprocal) denote the ways 
the filtered alignment results are handled before they are passed to the listed methods. 
‘Reciprocal’ means only reciprocal homologous relationships were passed to the 
implementation of this algorithm while ‘unilateral ’ means both reciprocal and unilateral 
homologous relationships were.  ‘Stringent’ means satisfying these cutoffs (evalue<=1e-30, 
alignment length>=200aa, percent identity>=50%, bit score>=200), ‘less stringent’ 
(evalue<=1e-30, alignment length>=120aa, percent identity>=50%, bit score>=150).   
 
 
 
Organism 
Contrast 
The number of matched homologs 
Maximum cardinality  Maximum weighted EGM 
[386] 
 
Homolo-
Gene 
[388] 
Uni 
Stringent 
Re 
Stringent 
Re 
 Less 
stringent  
 
Uni 
Stringent 
Re 
Stringent 
Re 
 Less 
stringent 
 
Mouse-Rat 18443 18360 20855 18402 
 
18322 20802 17799
(88%) 
17,882 
Mouse-Human 18528 18370 20529 18482 18339 20491 16214
(79%) 
18,473 
 
Mouse-Chicken 10773 10604 11898 10757 10593 11871 NA 13,149 
Mouse-
Zebrafish 
11095 10729 12310 11048 10705 12282 13850
(58%) 
14,183 
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Box 1. Bipartite Matching Glossary 
 
Graph: a graph is a set of interconnected objects also referred as vertices, being 
represented by G (V, E) in which V represent the set of vertices and E denotes the set of 
edges that describe the interconnected relationships among vertices. A graph is sometimes 
called a network and vertices are sometimes referred as nodes. 
 
Bipartite graph: a bipartite graph G (V (X, Y), E) is a graph has its vertices V being divided 
into two disjoint sets X and Y, and edges E being drawn between vertices in X and in Y. 
 
Matching: given a graph G (V, E), a matching M is a subset of edges of this graph that do not 
share common nodes.  
 
Bipartite matching: given a bipartite graph G (V (X, Y), E), a bipartite matching M (  ) 
is a subset of E that contains only non-adjacent edges (or, no two edges share a vertex) 
 
Cardinality: given a set, cardinality is a measure that tells the number of elements in this 
set. For example, a set has 10 elements, so its cardinality is 10. 
 
Maximum cardinality bipartite matching: given a bipartite graph G (V (X, Y), E), 
maximum cardinality bipartite matching is the matching M (  ) that maximizes 
cardinality, or the number of matched pairs, between the two partitions X and Y.  
 
Maximum weighted bipartite matching: given a bipartite graph G (V (X, Y), E) and the 
weights W (E) associated with the edges E, maximum weighted bipartite matching is the 
matching M (  ) that maximizes W (M), the sum of weights of edges in M.   
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CHAPTER 5 
 
  SUMMARY 
 
This thesis heuristically explored ways to decipher heterogeneous big data 
for useful clues that help to answer questions in an integrative way. Chapter 1 gives 
an overview of the big background, a brief description of rationale and specific 
objectives and a literature review that is essential to the specific objectives. 
Chapter 2 describes review work on prior knowledge to show developing 
retina is an excellent model to study cellular fate determination and differentiation 
in the context of a multicellular tissue, shows network models we constructed to 
summarize known gene interactions that underlie determination of each retinal cell 
type and displays how we leveraged high-throughput data to rediscover the 
network supported by experimental evidence. These networks provide a rational 
segue to systems biology approaches necessary to understand the many events 
leading to appropriate cellular determination and differentiation in the developing 
retina and other complex tissues. The ability of these networks to effectively focus 
the generation of hypotheses from high-throughput data sets would significantly 
advance the discoveries that depend on this type of data. It will be tremendously 
useful in the extrapolation of discovery in one model system to another if the 
network models are used to identify conserved networks act in similar ways. So 
investigation in more organisms is worth future effort.  
Chapter 3 describes tool development work on EnRICH that is able to 
qualitatively integrate multiple heterogeneous datasets and use different selections 
to filter each of them, provided the datasets are tables that have distinct identifiers 
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and attributes. A case study is presented to show how EnRICH is used to integrate 
and filter multiple candidate gene lists to identify potential retinal disease genes. As 
a result of the case study, a candidate pool of several hundred genes was narrowed 
down to five candidate genes, of which four are confirmed retinal disease genes.  
With EnRICH, biologists have an automated yet flexible integration tool to 
construct and analyze composite network and effectively prioritize candidate genes 
for further investigation. For the applications of EnRICH in network data, I name a 
few cases here. The first case is to extract interactions of interest out of huge 
amount of such information by filtering their attributes. For example, a mouse 
protein- protein network can be really huge for a biologist who is interested in 
mouse retinal development to look for valuable information.   Fortunately proteins 
in such a network are more likely to be functionally annotated. So the biologist can 
relay the function information of proteins to their interactions and then use EnRICH 
to get interactions of interest (e.g. only interactions that are composed by proteins 
who are known to work for retinal development are extracted).  The second case is 
to compare networks. For example, with a neural development network and a 
retinal development network, the biologist may want to know what are conserved 
or differentiated between the two networks. By using EnRICH to integrate the two 
networks, the biologist would easily discern the conserved from the differentiated, 
or vice versa.  The third case is to integrate across interaction data from different 
platforms. For example, to find out how genes may work with each other, the 
biologist may wish to leverage heterogeneous information such as protein-protein 
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interactions, genetic interactions, computationally predicted interactions for a more 
reliable hypothesis. With EnRICH, this can be easily done within minutes. 
Even though Current version of EnRICH can deal with heterogeneous intra 
-organism information.  The results of prioritization and integration may get 
improved with the addition of inter-organism information. This requires the 
addition of the function that is able to convert/map genes between organisms 
(research on conversion method led to Chapter 4).   
Chapter 4 describes a method we proposed to address the need of across-
genome matching in a one gene to one gene fashion. In this method, matching 
between any two genomes is modeled as a maximum bipartite matching problem 
and the algorithm of maximum weighted bipartite matching of specific cardinality is 
used to solve this problem. To implement this proposed method we created a 
python tool package called AGEM. The result from implementing this method on 
four pairs of organisms indicates this method is better than other methods in terms 
of the number of putative orthologs.  
Our method and tool AGEM enables biologists to generate dictionary to 
translate genes in a one-to-one fashion between any two genomes and thus has a 
broad use in integrating data across organisms, especially in leveraging model 
organisms to annotate non-model organisms. For example, studies on how genes 
interact with each other in the development of non-model organism cotton are very 
desirable due to the social-economic value of cotton. However, the lack of 
interaction data of cotton hinders such efforts. With AGEM, the biologist can map 
101 
 
sequences of cotton to Arabidopsis genes and thus leverage the interaction data of 
Arabidopsis to hypothesize gene interactions of cotton.   
By studying on the performance of this method, the relationship between 
global homology and the number of putative orthologs was discovered to follow a 
nonlinear growth model.  And parameters of the nonlinear growth model are relate 
to closeness of evolutionary relationships and thus could be used to predict 
unknown evolutionary relationships among organisms. Implementation of this 
method on more organisms can help determine at what relatedness the feature that 
is promising to predict evolutionary relationships is appropriate. 
Chapter 5 summarizes the results of previous chapters and points out where 
the future research should focus on. 
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APPENDIX A 
 
SUPPLEMENTARY INFORMATION (CHAPTER 2) 
 
Supplementary Table 1. A summary of genes regarded as important for retinal cell 
determination and differentiation in this study. Individual citations experimentally 
describe the developmental effect of a gene on the specification or differentiation of 
a specific cell type. 
 
GENE RETINAL CELL TYPE 
Muller Ganglion Bipolar  Amacrine  Horizontal  Photoreceptor  
Brn3b  [269, 272, 
389] 
    
Brn3a  [390]     
Brn3c  [391]     
Barhl2  [246]  [246, 
392] 
  
Chx10   [286]   [287] 
Crx      [299, 393] 
Dlx1  [394, 395]     
Dlx2  [394, 395]     
Irx5   [247]    
Lim1     [296]  
Islet1  [272, 273] [252] [252]   
Otx2   [288, 
289] 
  [288, 289, 
305] 
Pax6 [270, 271] [270, 271]  [256, 
270] 
[256, 270]  
Prox1     [292]  
Rax [258]      
RPF1  [396]     
Sox2    [241]   
Sox8 [243]      
Sox9 [243, 265]      
Bhlhb4   [228]    
Bhlhb5   [229] [229]   
Hes1 [249, 258, 
263] 
     
Hes5 [248, 263]      
Math5  [251, 266-
269, 271] 
    
Mash1   [283]    
138 
 
Math3   [254] [256]   
NeuroD    [256]  [297, 298] 
Ptf1a    [226, 
227] 
[226, 227]  
Ataxin7      [302, 303] 
BAF      [304] 
Eomes  [277]     
Nrl      [311] 
Nr2e3      [315, 318, 
319] 
RXRα      [331] 
RXRγ      [330] 
Shh   [351, 397]     
TRβ2      [298, 326] 
9-cis RA      [320, 321] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
139 
 
 
APPENDIX B 
 
ADDITIONAL FILES (CHAPTER 3) 
 
Additional file 1: Gene lists and their filtration criteria prior to integration. This file 
includes a supplementary table that displays names and descriptions of gene lists 
for integration in case study and some further explanation on the sources of gene 
lists. 
 
Supplementary Table 1. Gene Lists for integration and criteria on them for 
filtration 
Gene List  Gene List Description Attribute  Filter on 
attribute 
Potential candidate 
genes are expected 
to be 
Wt_Nrl.txt Genes coexpressed with 
Nrl across all five time 
points (E16, P2, P6, P10, 
4-WEEK) in wild type 
Spearman 
correlation 
coefficient 
>|0.9| Present 
 
Wt_Nr2e3.txt Genes coexpressed with 
Nr2e3 across all five 
time points (E16, P2, P6, 
P10, 4-WEEK) in wild 
type 
Spearman 
correlation 
coefficient 
>|0.9| Present 
 
Wt_Rho.txt Genes coexpressed with 
Rho across all five time 
points (E16, P2, P6, P10, 
4-WEEK) in Nrl-mutant. 
Spearman 
correlation 
coefficient 
>|0.9| Present 
 
Nrl_Nrl.txt Genes coexpressed with 
Nrl across all five time 
points (E16, P2, P6, P10, 
4-WEEK) in Nrl-mutant. 
Spearman 
correlation 
coefficient 
>|0.9| Absent 
Nrl_Nr2e3.txt Genes coexpressed with 
Nr2e3 across all five 
time points (E16, P2, P6, 
P10, 4-WEEK) in Nrl-
mutant. 
Spearman 
correlation 
coefficient 
>|0.9| Absent 
Nrl_Rho.txt Genes coexpressed with 
Rho across all five time 
points (E16, P2, P6, P10, 
4-WEEK) in Nrl-mutant 
Spearman 
correlation 
coefficient 
>|0.9| Absent 
 
Deg_Up.txt Up-regulated genes (Nrl- 
mutant VS. Wild type) 
Time points 
at which 
genes are 
P6, P10 Present 
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differentially 
expressed 
Deg_Down.txt Down-regulated genes 
(Nrl- mutant VS. Wild 
type) 
Time points 
at which 
genes are 
differentially 
expressed 
P6, P10 Present 
 
 
Note: The GEO dataset GSE4051 [332] is used to prepare differentially expressed 
gene lists and coexpressed gene lists.  Differentially expressed genes between wild 
type and Nrl-mutant at four developmental time points (E16, P2, P6 and P10) are 
obtained with the cut-off q-value controlled at 0.05 (For details, see Additional file 
3). Coexpressed genes of Nrl/Nr2e3/Rho are obtained by calculating Spearman 
correlation coefficients between Nrl/Nr2e3/Rho and other genes across the five 
time points (developmental stages) from wild type and Nrl-mutant. R [398] and R 
packages (affy [399], limma [400], qvalue [401]and doBy[402]) are used to do the 
computation. All lists in the above table can be downloaded from 
http://xiazhang.public.iastate.edu/demo.html 
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Additional file 2: Gene candidates resulting from the EnRICH filtration and 
prioritization analyses. This file is the supplementary table of the five gene 
candidates from the prioritization by using EnRICH in case study.  
Gene 
symbol 
Full name 
Previously known 
retinal disease genes 
NCBI 
Links 
Wikigenes 
Links 
pde6b 
phosphodiesterase 6B, 
cGMP, rod receptor, beta 
polypeptide 
yes 
1 6 
cnga1 
cyclic nucleotide gated 
channel alpha 1 
yes 
2 7 
gnb1 
guanine nucleotide 
binding protein (G 
protein), beta 1 
yes 
3 8 
kcne2 
potassium voltage-gated 
channel, Isk-related 
subfamily, gene 2 
no 
4 9 
guca1a 
guanylate cyclase 
activator 1a (retina) 
yes 
5 10 
1: http://www.ncbi.nlm.nih.gov/gene/18587 
2: http://www.ncbi.nlm.nih.gov/gene/12788 
3: http://www.ncbi.nlm.nih.gov/gene/14688 
4: http://www.ncbi.nlm.nih.gov/gene/246133 
5: http://www.ncbi.nlm.nih.gov/gene/14913 
6: http://www.wikigenes.org/e/gene/e/18587.html 
7: http://www.wikigenes.org/e/gene/e/12788.html 
8: http://www.wikigenes.org/e/gene/e/14688.html 
9: http://www.wikigenes.org/e/gene/e/246133.html 
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http://www.wikigenes.org/e/gene/e/14913.html 
 
 
Note:  
Red: genes coexpressed with nrl, nr2e3, rho in wildtype and are not coexpressed 
with these genes in nrl-mutant, but are down regulated at p6, p10 (like rho and 
nr2e3) in nrl-mutant     
Green: genes coexpressed with nrl, nr2e3, rho in wildtype and are not coexpressed 
with these genes in nrl-mutant, but are up regulated at p6, p10 (like rho and nr2e3) 
in nrl-mutant     
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Additional file 3: Description of data processing. This file includes detail 
description of data pre-processing for case study, and analysis of the significance of 
case study result. 
 
The Differentially Expressed Genes (DEGs) of GSE 4051 
GSE 4051 [332] is a dataset of Affymetrix arrays. We downloaded the dataset 
GSE4051_RAW.tar from NCBI database Gene Expression Omnibus (GEO) [82]. We 
used R Packages to analyze this dataset. The package ‘affy’ [399] is used to read and 
pre-process the raw data. The package ‘limma’ [400] is used to fit the linear model 
(see below), and compute empirical Bayes moderate t-statistics. In order to control 
multiple testing FDR (False Discovery Rate) at 5%, we also used the package ‘qvalue’ 
[401] to compute q-values and set the cut-off as 0.05. 
 
Linear model 
GSE 4051 [332] profiles gene expression in isolated rod photoreceptors at 
five developmental stages (E16, P2, P6, P10 and 4-weeks) from wild type and Nrl-
knockout. We are interested in what genes respond differently between wild type 
and Nrl-knockout at each of the four developmental stages (E16, P2, P6 and P10). So 
our linear model takes the mathematical form: 
   	   	   	  	  	  
Where the responsible variable  represents signal intensity for genotype i, 
time point j and biological replication k. The parameter  denotes the average 
effect,   is the fixed effect of genotype,    is the fixed effect of developmental 
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stage,    indicates the interaction between genotype i and developmental stage j, 
 represents the fixed effect of replicate k, and  is the random error. 
 
The Significance of the Case Study Results 
We found 272 unique differentially expressed genes from the analysis of GSE 
4051 [332]. The exclusion of three genes (Nrl, Nr2e3 and Rho are bait genes) results 
in a candidate pool of 269 genes. By using EnRICH to prioritize this candidate pool, 
we obtained five genes with the highest priority, and four of them are confirmed 
retinal disease genes. According to our search for Retinal Disease Genes (see below), 
only one previously known retinal disease gene (Rbp3) was not re-discovered by 
EnRICH. The Fisher’s exact test (see below) also indicates retinal disease genes are 
significantly enriched in the fived prioritized candidate genes.  
 
Search for Retinal Disease Genes  
We used NCBI database Genetics Home Reference [403] to search for the list 
of documented genes that contribute to the genetic conditions of Retinitis 
Pigmentosa (Retinitis pigmentosa is a retinal disease caused by abnormalities of the 
photoreceptor rods and cones or the retinal pigment epithelium).  Genes prioritized 
by EnRICH were compared to this list to determine if they were known retinal 
disease genes. 
 
Fisher’s exact test 
We performed a Fisher’s exact test to check for enrichment of retinal disease 
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genes in the high priority genes identified using EnRICH. 
 Known as retinal disease genes?  
Yes No 
Identified as 
high priority by 
EnRICH? 
Yes 4d 1e 5b 
No 1f 263g 264c 
 5h 264k 269a 
a The total number of genes in the candidate pool 
b The total number of genes selected by EnRICH 
c Tthe total number of genes not selected by EnRICH 
d The number of genes that are selected by EnRICH as well as known as retinal 
disease genes 
e The number of genes that are selected by EnRICH yet not known as retinal disease 
genes 
f The number of genes that are not selected by EnRICH yet known as retinal disease 
genes 
g The number of genes that are neither selected by EnRICH nor known as retinal 
disease genes 
h The total number of genes that are known as retinal genes in the candidate pool 
k The total number of genes that are not known as retinal genes in the candidate 
pool 
 
Test result computed by R: 
p-value = 1.168e-07 
Alternative hypothesis: true odds ratio is not equal to 1  
95 percent confidence interval: 
3.806447e+01 4.503600e+15  
 
The p-value for this test is extremely small, from which we can reject the null 
hypothesis that retinal disease genes are equally represented between genes 
selected by EnRICH and genes not selected by EnRICH. Alternatively, the test result 
favors the hypothesis that retinal disease genes are overrepresented in genes 
selected by EnRICH. 
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APPENDIX C 
 
TECHNICAL SUPPLEMENT (CHAPTER 4) 
 
Part 1:  Definition of the glossary  
 
Graph: a graph is a set of interconnected objects also referred as vertices, being 
represented by G (V, E) in which V represents the set of vertices and E denotes the 
set of edges that describe the interconnected relationships among vertices. A graph 
is sometimes called a network and vertices are sometimes referred as nodes. 
 
Bipartite graph: as shown in Figure 1, a bipartite graph G (V (X, Y), E) is a graph 
has its vertices V being divided into two disjoint sets X and Y, and edges E being 
drawn between vertices in X and in Y. 
 
Matching: given a graph G (V, E), a matching M is a subset of edges of this graph that 
do not share common nodes.  
 
Bipartite matching: given a bipartite graph G (V (X, Y), E), a bipartite matching M 
(  ) is a subset of E that contains only non-adjacent edges (or, no two edges 
share a vertex) 
 
Cardinality: given a set, cardinality is a measure that tells the number of elements 
in this set. For example, a set has 10 elements, so its cardinality is 10. 
 
Maximum cardinality bipartite matching: as shown in Figure 2, given a bipartite 
graph G (V (X, Y), E), maximum cardinality bipartite matching is the matching M 
(  ) that maximizes cardinality, or the number of matched pairs, between the 
two partitions X and Y.  
 
Maximum weighted bipartite matching: as shown in Figure 3, given a bipartite 
graph G (V (X, Y), E) and the weights W (E) associated with the edges E, maximum 
weighted bipartite matching is the matching M (  ) that maximizes W (M), the 
sum of weights of edges in M.   
 
 
 
Part 2: Description of the method 
 
Maximum cardinality bipartite matching:  a bipartite matching in which cardinality 
reaches maximum. 
 
Maximum weighted bipartite matching: a bipartite matching in which global weight 
reaches maximum. 
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The two types of bipartite matching differ in the quantitative measure from 
which they seek maximum.  One is cardinality (the number of matched pairs) and 
the other is global weight (the sum of weights that are associated with matched 
pairs).  In some cases, there might be a trade-off between cardinality and global 
weight (Figure 4).  So to have a legitimate/appropriate balance between cardinality 
and global weight, it is necessary to associate them together in a way that the 
maximum of either of them can be considered along the scale of the other. In our 
method, we considered global weight along the scale of cardinality.  
 
For a given a bipartite graph    , 
", ", its bipartite matching as  
   " is a subset of edges E that contains only non-adjacent edges. The number 
of edges in  is called its cardinality # $ %#&'(,  #&)*, where #&'(=0 and kmax 
=maximum cardinality that  can have.  The sum of weights that are associated 
with all edges in  is its global weight Wms. There are two things worth noting 
here: 
 
1. It is possible there are multiple  with the same #. For example, for 
bipartite graph in figure 5, there are two   that have the same cardinality 3.  
2. It is possible that there are multiple  with the same # and different Wms. 
For example, the two bipartite matchings in figure 5 have different Wms.  
 
In other words, for a given bipartite graph and for any 
cardinality # $ %#&'(,  #&)* , there could be multiple bipartite machings  that 
could have different global weights Wms.  Based on this, a good way to consider 
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global weight along the scale of cardinality would be to rate the maximum of global 
weight against the scale of cardinality. That is, for each Km, to consider only the Mg 
that has the largest global weight. This could be dissected into two parts: the first is 
to look for the  that has the largest global weight for each  #.  The second is to 
# has to be increased from #&'( to kmax by one each time. The legitimacy of 
incremental computation has been proven in previous works on bipartite matching, 
for more technical details in computer science, we refer the reader to the cited 
works [404-407]. 
 
 
Part 3: Execution of the algorithm 
 
#: the cardinality of a bipartite matching that ranges from #&'( to kmax 
+&): the bipartite matching that has maximal global weight 
D: the dictionary that stores cardinality # $ %#&'(,  #&)* as keys and the 
maximum weighted bipartite matching +&) for each # as values 
we:  the weight that is associated with each edge e $  in a given bipartite graph 
   , 
", " .  
wadj: the adjusted weight that is associated with each edge e $  in a given bipartite 
graph    , 
", " .  
 
 
1. Load bipartite graph    , 
", ", convert G to , by : 
1.1 Making undirected edges to directed edges( -. to  -/.), and for each edge 
e $ , wadj= wm	max(wm) 
1.2 Source vertex s is connected to vertex x $ X, and target vertex t is connected 
to vertex y $ 
, and make 012-=0 and 0.23=0. 
 
2. Set #=0, +&)=4, D={key: #, value: +&)} 
 
3. While (there exists augmenting path with respect to +&) ) do: 
1). Search for an augmenting path p with minimal weight using Dijkstra’s 
algorithm (compute the shortest path from s to t in ,, the corresponding path 
in G is augmenting path p with minimal weight).  
 
2) Invert p and increases +&) by one edge: 
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3) Recalibrate all directed edges (assuming from vertex u to vertex v) in , that 
are not included in p by function +5/6=78/9 	 :5  :6 (this function makes 
+5/6 ; < be satisfied so Dijkstra’s algorithm can be used). 
 
4) D [#] = +&) 
 
5) #  # 	 = 
 
  4.  Output D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1. Bipartite Graph.  The blue nodes represent one party while the orange 
nodes the other party.  
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 Figure 2. Maximum cardinality bipartite matching.
represent nodes in a bipartite graph and lines drawn between them are edges in this 
bipartite graph. Numbers on the top of lines are weights associated with these 
edges.  Strokes in red denote a maximum cardinality bipartite matching. 
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 The nodes in blue and orange 
 
 
 Figure 3. Maximum weighted bipartite matching. The nodes in blue and orange 
represent nodes in a bipartite graph and lines drawn between them are edges in this 
bipartite graph. Numbers on the top of lines are weights associated with these 
edges.  Strokes in red denote a maximum weighted bipartite matching. 
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 Figure 4.  The trade-off between cardinality and weight. The nodes in blue and 
orange represent nodes in a bipartite graph and lines drawn between them are 
edges in this bipartite graph. Numbers on the top of lines are weights associated 
with these edges.  Strokes in red denote th
represent a bipartite matching that has a cardinality of 4 and a global weight of 55. 
Red strokes in B represent a bipartite matching that has a cardinality of 3 and a 
global weight of 150. 
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e bipartite matching. Red strokes in A 
 
 Figure 5.  Bipartite matchings with the same cardinality. The nodes in blue and 
orange represent nodes in a bipartite graph and lines drawn between them are 
edges in this bipartite graph. Numbers on the top of lines are weights associated 
with these edges.  Strokes in red denote the bipartite matching. Red strokes in A 
represent a bipartite matching that has a cardinality of 3, and red strokes in B 
represent another bipartite matching that also has a cardinality of 3. The matching 
in A has a global weight different 
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from that of the matching in B. 
 
